Walden University

ScholarWorks
Walden Dissertations and Doctoral Studies

Walden Dissertations and Doctoral Studies
Collection

2019

Understanding the Lived Experience in Women
With Psoriatic Disease Utilizing Alternative
Interventions
Lisa Liimatainen
Walden University

Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Psychology Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been
accepted for inclusion in Walden Dissertations and Doctoral Studies by an authorized administrator of ScholarWorks. For more information, please
contact ScholarWorks@waldenu.edu.

Walden University
College of Social and Behavioral Sciences

This is to certify that the doctoral dissertation by

Lisa Liimatainen

has been found to be complete and satisfactory in all respects,
and that any and all revisions required by
the review committee have been made.
Review Committee
Dr. Alethea Baker, Committee Chairperson, Psychology Faculty
Dr. Susan Rarick, Committee Member, Psychology Faculty
Dr. Brandy Benson, University Reviewer, Psychology Faculty

Chief Academic Officer
Eric Riedel, Ph.D.

Walden University
2019

Abstract
Understanding the Lived Experience in Women With Psoriatic Disease Utilizing
Alternative Interventions

by
Lisa Liimatainen

MS, Walden University, 2012
BS, University of Phoenix, 2009

Dissertation Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy
Psychology

Walden University
May 2019

Abstract
Psoriatic disease (PD) is an autoimmune disease that affects millions of women and
currently has no cure. Examining the lived experience of women with PD who choose to
treat their disease with alternative methods may allow for deeper understanding of how
mental health professionals can support their choices. Using phenomenology, this study
looked at the experiences of these women through theories of self-efficacy and self-inrelation theory, theories that empower and speak to women. The participants consisted of
women who reported a diagnosis of PD, who reported they had abstained from
pharmaceutical interventions for at least the previous six months. The sample size
consisted of 7 participants, recruited through social media, from various parts of the
world. Explication was used to assess the data and consisted of the following: bracketing
and phenomenological reduction, delineating units of meaning, clustering of units of
meaning to form themes, summarizing each interview, and extracting general and unique
themes from all interviews and making a composite summary. The findings of this study
showed that the participants reported feeling capable of pursuing health options that
aligned with their values and were not opposed to pharmaceutical options at some point.
In addition, findings indicated participants felt minimal, if any, support from their
medical care providers. The results of the study may facilitate positive social change by
informing women with PD about the benefits of taking an active role in treatment
planning. Further, this study’s results may expand knowledge about treatment of women
with PD and inform medical professionals, specifically mental health professionals, about
what is important to these women in terms of a treatment plan.
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Chapter 1: Introduction to the Study
Introduction
Psoriatic disease (PD) is an autoimmune disease that affects over 70,000,000
people worldwide (Eder, Chandran, & Gladman, 2012). The aim of this study was to
look at the lived experiences of women with PD who have chosen to treat their disease
without pharmaceutical intervention. PD consists of psoriasis and psoriatic arthritis
(PsA). In much of the literature on PD, researchers have combined males and females in
the same study or have looked only at specific pharmaceutical interventions. Thus, the
literature does not cover the full scope of PD. Often, PsA and psoriasis have been
separated in these studies (Eder et al., 2012; Lesuis, Befrits, Nyberg, & van Vollenhoven,
2012; Papoutsaki & Constanzo, 2013;).
A better understanding of the patient’s decision-making process and the factors
considered during that process may provide insight into the reason(s) for a person’s
choice to seek natural therapies (Dudlettes, 1986). Researchers have found that quality of
life is lower in people with PD. However, there is a need to know how people treat their
PD and how they decide on a means of treatment (Boehncke & Menter, 2013; Eder et al.,
2012; Mease, 2012). Through this study, I sought to fill this gap in the literature.
Participants in the study had the opportunity to openly discuss their thoughts and the
factors they considered in order to decide on a treatment. This facilitated an increased
understanding about their daily struggle with PD (Eder et al., 2012).
This study has the potential to facilitate positive social change in a number of
ways. This study may help to further the knowledge base of mental health professionals
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in regard to PD and the psychological comorbidity that often accompanies it (Ferreira,
Abreu, Reis, & Figueiredo, 2016). The results of this study may inform women with PD
about the benefits of taking an active role in their choice of treatment. In addition, the
study’s results add to the literature about treatment of women with PD and may inform
medical professionals about what is important to these women when they consider a
treatment plan.
This chapter provides brief background on the current literature, as well as the
problem statement, purpose, and research question of the study. It includes an
introduction to the study’s theoretical framework, the nature of the study, definitions of
key terms, and a discussion of the study’s assumptions, delimitations, limitations, and
significance.
Background
PD has often been put in the same category as other chronic conditions or thought
of as only a disease of the skin. Yet beyond the skin, there is a lot happening in the body
in patients with PD. PD is an autoimmune disease experienced by approximately 1-3%
of the world population, and currently there is no known cure (Eder et al., 2012).
PD consists of psoriasis and PsA. Psoriasis, a chronic inflammatory skin
disorder, will usually present itself first. Skin cells reproduce at an accelerated rate,
which results in patches of scaly skin on various areas of the body. Of those diagnosed
with psoriasis, roughly 20% will develop PsA (Boehncke & Menter, 2013; Kotsis et al.,
2012). PsA is an inflammatory seronegative spondyloarthropathy that primarily affects
peripheral joints (Boehncke & Menter, 2013). Symptoms of PsA are centered around the
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joints but can also affect the surrounding ligaments and tendons. These symptoms
include stiffness, pain, swelling, and tenderness (Papoutsaki & Costanzo, 2013). These
symptoms can be irregular and spontaneous, leaving people with a guessing game of
which joint or area of the body will be affected next and for how long. The outside and
the inside of the body are susceptible, leaving the person seemingly at the mercy of the
disease.
While the specific causes of the disease are unknown, it is believed to be caused
by multiple factors including genes, the immune system, and environmental factors
(Starkebaum, 2015). Psoriasis is often seen and managed in a family practice
environment (Magin, Adams, Heading, Pond, & Smith, 2009). There are a number of
pharmaceutical treatment options for PD, meant to reduce inflammation in the body and
treat the symptoms of the disease (Mease, 2012). However, some people who are
diagnosed with PD choose to avoid pharmaceutical interventions in favor of a more
natural route. Less literature exists on this population even though trends are showing an
increase in complementary and alternative medicine (Su & Li, 2011).
Males and females are equally vulnerable to PD, with women being more likely to
discontinue their pharmaceutical interventions for PD due to lack of effectiveness and
side effects and to suffer worse quality of life (Eder et al., 2012). In the context of living
day to day with PD, it can be overwhelming to choose a treatment plan. However, it is
not known how and why women choose their type of treatment. Women may tend to
consider how others in the family may be affected. Family obligations can combine with
a woman’s need for full-time employment—at a time when she may also worry about the
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hereditary nature of PD and whether or not her child or children will be affected.
Numerous studies have shown that those with PD suffer from a lower quality of life, but
what is missing is understanding of how this population decides on a treatment plan and
why those with PD may choose a nonpharmaceutical approach over conventional
medicine (Boehncke & Menter, 2013; Eder et al., 2012; Mease, 2012). A Swedish study
on psoriatic patients found that female patients (as opposed to male patients) tended to
believe that they had an influence over their disease. This belief can lead patients to take
greater responsibility for the disease (Lesuis et al., 2012). Women are the specific
population for this study due to their quality of life being lower than men in this
population and due to women receiving less benefit with current pharmaceutical options
(Eder et al., 2012). A better understanding of this population has the potential to help
health care professionals in varying capacities to be of greater support.
Lastly, those with PsA have a higher risk of mental illness. Those with psoriasis
have a 39% greater chance of being diagnosed with depression and a 31% higher risk of
being diagnosed with anxiety (Leavitt, 2015). While this increase is staggering, it was
noted by Leavitt (2015) that depression and anxiety may result not only from the disease,
but also from the treatment. Mental health professionals need to be aware of the impact
that PD has on those affected while also developing an understanding of how to access
and serve this population. Psychodermatology is a new area of medicine that looks
specifically at the “interaction of body and skin” (Jafferany, 2011, p. 1). This field helps
connect the varying components involved in a disease such as PD. In addition, mental
health professionals should be aware of the psychosocial aspect of the disease and how
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individuals cope with PD and interact in the world around them. With ongoing support,
members of this population may cope and even thrive.
Problem Statement
Research indicates that PD dramatically reduces patients’ quality of life. For
example, PD can impair a person’s relationships, social life, and routine, day-to-day
activities. PD should not only be considered a physical disease; the psychological impact
of the disease also needs to be addressed (Grozdev et al., 2012). Currently, there is no
known cure for PD, so improvement of patients’ quality of life is the goal via symptom
management. As mentioned earlier, there are many options for pharmaceutical treatment
of PD, and researchers continue to find ways to reduce inflammation in the body. These
options are meant to treat symptoms of the disease (Mease, 2012).
While it is known that women tend to have less success with pharmaceutical
interventions for PD, it is not known how a treatment plan is decided on by a woman with
PD. It is difficult to know if this limited pharmaceutical treatment success impacts the
treatment choice or if these women are even aware of the increased risk of side effects.
Many medical doctors prescribe medication for PD—often, patients receive numerous
medications in an effort to combat the disease—but they may do so without
understanding the personal implications of treatment for the patient.
As mentioned above, decisions about treatment options for PD are difficult,
especially as women see themselves as relational (Surrey, 1985). Women tend to view
themselves in terms of their relationships, whether personal or professional.
Unfortunately, the problem is that women with PD are being underserved even though
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they are a vulnerable population that is likely to suffer from negative psychological
impacts of a disease with no cure (Magin et al., 2009).
Previous studies have sought to examine the psychological effects of psoriasis or
PsA (Boehncke & Menter, 2013; Grozdev et al., 2012; Magin et al., 2009; Sarilar, Koic,
& Dervinja, 2011) without specifically looking at females or treatment option
considerations. Female patients have been shown to respond less to pharmaceutical
interventions and to suffer more side effects, yet they are often combined with males in
these studies. None of the studies that have been conducted sought to examine the
decision-making process of this population and how patients come to decide on a
treatment plan. The Swedish study mentioned earlier found that women tend to feel that
they have more influence over the disease, which may lead them to take greater
responsibility over their disease (Lesuis et al., 2012), yet how this may manifest is not
known. Examining the lived experiences of women with PD who have chosen to treat
their disease nonpharmaceutically could lead to a better understanding of this population
and how its members can best be served.
An understanding of the decision-making process may help mental health
professionals obtain perspective on the complexities of a disease that is as pervasive as
PD. Mental health professionals need to be cognizant of women diagnosed with PD, as
they have an increased risk of anxiety and depression. As complementary and alternative
therapies have been increasing in popularity (Kelly, Cudney, & Wienert, 2012), mental
health professionals also need to be able to adjust their tools to properly serve this
population.
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Purpose of the Study
The purpose of this study was to examine the lived experience of women with PD
who had chosen to eschew pharmaceutical intervention in favor of natural alternatives.
The study helps to fill a gap in the literature regarding how women make decisions about
treatment of PD. Another purpose of the study was to provide increased understanding
about this population, which could be beneficial not only to women, but also to those
physical and mental health practitioners who work with them. Overall, the results of the
study could facilitate positive social change.
Research Questions
RQ1. What is the lived experience for women with PD who choose alternative
or complementary interventions as opposed to pharmaceutical
interventions?
RQ2. How do they feel about the treatment decision they made, and what
benefits have they noticed?
Theoretical Framework
The theoretical framework for this study was based on two theories: self-efficacy
theory (Bandura, 1997) and self-in-relation theory (Surrey, 1985). Bandura’s selfefficacy theory provides a lens through which to view and understand chronic disease.
Self-efficacy theory informed this study regarding how to understand a person’s
confidence in his or her own ability to control motivation, behavior, and the social
environment (Bandura, 1997). As mentioned earlier, previous research has found that
women with psoriasis tend to believe that they have some influence over their disease
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(Lesuis, 2012). Self-efficacy theory informed the current study in terms of how self
efficacy played a role in women’s decision-making process regarding treatment options
for PD.
Self-in-relation theory is specific to female development and works well with
self-efficacy theory. This theory was developed by Surrey (1985), who explained this
theory as addressing how women identify themselves in the context of important
relationships. Being able to understand women with PD in terms of how they decide on
their treatment plan in this context may yield valuable information that leads to a better
understanding of the complexities of this experience and how to best serve this
population. Women were the focus of this study due to the fact that women tend to suffer
from a lower quality of life than men living with PD (Eder et al., 2012). Taking into
account a women’s perspective provides a more accurate picture of women’s experience.
These theories will be looked at in greater depth in Chapter 2.
Nature of the Study
The nature of this study was qualitative. The qualitative approach allowed for a
deeper understanding of the participants and how their thought processes worked through
determining their treatment plan. It has been shown that women with PD suffer from
worse quality of life than men with PD, yet little is known about how this looks in their
lives (Eder et al., 2012). The specific methodology used was phenomenology, through
which I sought to describe the lived experiences of these women in terms of how they
went through the process of deciding on a treatment plan that did not include
pharmaceutical interventions. Most of the research that had been conducted had not
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sought to examine the lived experience of women with PD (Magin et al., 2009).
Participants were interviewed until the data were saturated, with no new themes
emerging. Phenomenology focuses on interviews (Creswell, 2014). Open-ended
questions were asked to elicit the responses needed to allow for an open and thoughtful
dialogue.
Definitions
The following key terms are used throughout the research.
Nonpharmaceutical interventions: This term applies to any treatment that does not
consist of prescription medications. This term has been used interchangeably throughout
this paper with natural and alternative treatments.
Psoriasis: Psoriasis is the aspect of PD that affects the skin. It is a chronic
inflammatory disease (Boehncke & Menter, 2013).
Psoriatic arthritis (PsA): PsA is an inflammatory joint disease that does not have
the blood antibodies associated with rheumatoid arthritis, which is referred to as
seronegative spondyloarthropathy (Boehnke & Menter, 2013). At times, when the term
PsA is used in this paper, it specifically pertains to the joint inflammation aspect of the
disease and not necessarily to the skin portion of the disease. Given that researchers have
often chosen to focus on either PsA or psoriasis, some information only pertains to that
specific area of the disease.
Psoriatic disease (PD): PD is a relatively new term that encompasses the various
“manifestations of tissue and organ involvement observed in many psoriasis patients”
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(Ritchlin, 2009, p. 1). PD is used throughout this paper for consistency and with the
understanding that it includes psoriasis and psoriatic arthritis.
Assumptions
There were a few assumptions for this study that I believed but could not prove to
be true. The first assumption was that the participants were honest about their diagnosis
of PD and that they had used only alternative treatments for at least the last 6 months.
The assumption also existed that these people generally wanted to decrease their
symptoms. Those participating in the study had the intent of improving their quality of
life and reducing symptoms through the use of natural or alternative treatments. These
assumptions were necessary, as it would have been difficult to have diagnoses verified
along with treatment options and duration of treatment.
Scope and Delimitations
The scope of this study focused on women diagnosed with PD who were treating
their disease with nonpharmaceutical interventions at the time of the study and sought to
understand their lived experiences when deciding on a treatment plan. This topic was
meant to bring attention to this specific timeframe of the disease while examining what
women take into consideration and how they come to treat their disease
nonpharmaceutically. Examining personality factors and the five-factor model was a
consideration at the start of the research process; however, based on the research, I
decided to begin by examining the lived experiences of these women. The results of this
study may lead to a closer study of personality factors in those women who choose to
treat their PD nonpharmaceutically.
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Women were specifically examined to better understand the impact of relational
roles on the choice of treatment. Males in the same scenario might be an appropriate
topic for future research, but to gather as much data as possible for one population, only
women were used for this study. Women aged 18 years and older of any ethnicity were
allowed to participate. This may have affected transferability, given the possible
diversity of the sample. However, the scope of the study involved understanding the
lived experience of women, so perhaps future research could narrow down this group if
need be.
Limitations
One limitation of this study was that it does not transfer to all women diagnosed
with PD who are not using pharmaceutical interventions. The issue of transferability was
previously discussed and was a limitation of the study. Another limitation was the
interview question guide, in that it did not include all questions that needed to be asked.
The final limitation was that the interviews were conducted via Facetime or using audio
only. This mode may have impacted rapport building.
Biases are a common concern in qualitative research, as the researcher is the
instrument. I would like to disclose that I have been diagnosed with PD and have
experienced the process of deciding on a treatment plan. I was constantly vigilant of my
own stance so that the words of the participants and their experiences were the center of
the study. Participants were given the opportunity to review their summaries to ensure
that their points were conveyed.
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Significance
The significance of this study is that it may help readers to understand the severe
impairment that PD can create. Examining how women choose their treatment can help
mental health professionals understand how to approach women with chronic conditions
and understand their decision-making process when it comes to deciding on a treatment.
Previous studies have shown that those with PD have a lower quality of life, but what is
missing is an understanding of how and why people treat their PD in the way that they
have chosen (Boehncke & Menter, 2013; Eder et al., 2012; Mease, 2012). The risk of
anxiety and depression with PD cannot be ignored. The costs of treating those with PsA
can reach almost $2 billion each year (Lee, Mendelsohn, & Sames, 2010). Currently, no
cure for PD exists, so symptom management and reduction are the targets, and the focus
of treatment is maintaining or improving quality of life. Women were the focus of this
study, as they tend to suffer from a lower quality of life than men when living with PD
(Eder et al., 2012). A previous Swedish study on psoriatic patients suggested that
females may be more likely than males to believe in the influence they have on their
disease and therefore take greater responsibility for their disease management (Lesuis et
al., 2012).
Summary
This chapter laid out the study and its basis. PD is classified as an autoimmune
disease that consists of psoriasis and PsA. Psoriasis is defined as a systemic
inflammatory disease that affects up to 3% of the population (Velez, Wei-Passanese,
Husni, Mody, & Quereshi, 2012). An estimated 10-30% of those with psoriasis will
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eventually develop PsA, which is a “chronic inflammatory and progressive arthritis”
(Velez et al., 2012, p. 7). PD has been shown to affect men and women at similar rates;
however, the presentation of the disease can vary greatly across genders and individuals,
with these differences possibly being partly attributable to social expectations of females
(Eder et al., 2012).
Examining the lived experiences of women with PD and how they decide on a
treatment that does not include pharmaceutical interventions may lead to a greater
understanding of the thought process for female PD patients, which may help medical
professionals, including mental health professionals, better care for this vulnerable
population. Mental health professionals have an obligation to serve this population,
given members’ increased risk of mental health issues. Because PD is often diagnosed in
the early adult years and has no cure, the ability to serve this population’s mental health
needs is vital.
The next chapter provides an in-depth literature review of what is currently
available regarding PD, women with PD, PD treatments, and relevant theoretical
frameworks.
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Chapter 2: Literature Review
Introduction
PD encompasses the diagnoses of psoriasis and PsA. While PD is a relatively
new term, it seeks to bring together psoriasis and PsA. A subset of those diagnosed with
psoriasis will go on to develop PsA. This paper’s focus was on those diagnosed with PD,
not solely psoriasis. Not all research has grouped psoriasis and PsA together and
identified them as PD. It was my intent to bring this research together to aid in the
creation of a complete picture of PD. The term PD is used throughout this paper for
continuity purposes and with the understanding that it includes psoriasis and PsA. At
times, when the terms psoriasis and PsA are used, it should be noted that they pertain
specifically to the one aspect of the disease that each represents and not necessarily to
one another. Given that research has often chosen to focus on either PsA or psoriasis,
some information only pertains to that specific area of the disease.
PD has often been grouped in with other chronic conditions. It may also be
classified simply as a skin disease, but there is much more happening within the body
than what is seen on the skin. PD is an autoimmune disease that affects roughly 3% of
the world population, and currently no cure exists (Eder et al., 2012). Psoriasis usually
presents itself first by attacking the skin. There are numerous types of psoriasis,
including plaque, flexural, erythrodermic, pustular, guttate, and nail psoriasis (Papoutsaki
& Costanzo, 2013). Each of these types has different appearances, but all cause the body
to reproduce skin cells within days as opposed to weeks (Eder et al., 2012).
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While the specific origin of the disease is unknown, it is believed to be caused by
multiple factors, including genes, the immune system, and environmental factors
(Starkebaum, 2015). Of those diagnosed with psoriasis, roughly 20%, which comes to
between 14,000,000 to 42,000,000 people worldwide, will develop PsA (Boehncke &
Menter, 2013; Kotsis et al., 2012). PsA involves inflammation encompassing not just the
skin, but also other areas of the body, primarily joints.
Research suggests that roughly 1 million Americans currently have PsA, and the
numbers are increasing (Hammadi, 2016). Little is known about the cause of PsA, which
can make it difficult to fully grasp the enormity of the impact of the disease. Various
sources suggest that the cause is multifaceted and includes genetics, infections, trauma,
and environment (Eder et al., 2012; Liu et al., 2014; Papoutsaki & Costanzo, 2013). The
purpose of this research was to examine the decision-making process of women with PD
who have chosen to eschew pharmaceutical intervention in favor of natural alternatives.
Understanding women’s reasoning in choosing a treatment route will allow for a clearer
understanding of how mental health professionals can be a support to this population
whose members are vulnerable to mental health issues such as depression and anxiety
(Grozdev et al., 2012; Magin et al., 2009).
This chapter explores PD in relation to its diagnosis, symptomology, and
treatment, as well as how women specifically are affected in various life areas by PD and
why their unique experience with PD needs to be more closely studied. The numbers for
those affected with PD have been shown to be growing (Boehncke & Menter, 2013), so it
is imperative that those affected are better understood and respected, no matter their

16
treatment choice. It is estimated that 2.5% of the North American Caucasian population
is affected by PD, with males and females being equally susceptible (Eder et al., 2012;
Hammadi, 2016).
Women tend to take their relational obligations into consideration when choosing
a treatment. Research has shown that pharmacological options have lower efficacy for
women than they do for men (Eder et al., 2012). Women with PD were chosen for this
study because they have been shown to have a lower quality of life than men diagnosed
with PD (Hammadi, 2016; Magin et al., 2009) and to experience complexities in their
decision-making process regarding PD treatment, particularly with respect to important
relationships and the impact that their treatment choice may have on those relationships.
The theoretical frameworks I used for this study offered some understanding of how
confident individuals may be in their ability to choose a treatment option and how women
tend to view themselves and their health in relation to others.
The two theories that I used to help bring understanding of women diagnosed
with PD were self-in-relation theory and self-efficacy theory. Self-in-relation theory
specifically looks at women and their development and how women take into
consideration important relationships that have bearing on their identity (Surrey, 1985).
This variation in identity formation can be further complicated when women are faced
with a chronic disease and the impact it will have on not only their lives, but also the
lives of those with whom they have important relationships, such as significant others,
children, aging parents, and coworkers. Bandura described self-efficacy as a person’s
confidence in his or her ability to control motivation and behavior, noting that social
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environment can play an integral role in determining self-efficacy (Bandura, 1997). By
applying self-efficacy theory to women with PD, I was able to gain a better
understanding of how in control these women felt in relation to deciding on a treatment
option and their confidence that they could carry out what was necessary.
This chapter provides clarification regarding the literature on the topic of PD,
self-in-relation theory, self-efficacy theory, mental health treatment, and
nonpharmaceutical interventions. The few qualitative studies that exist on PD and those
that look at quality of life have neglected to fully capture the thought process in how
people decide on treatment plans; rather, the focus has been on how patients feel in
regard to the diagnosis and living with the disease (Magin et al., 2009; Sarilar, Koic, &
Dervinja, 2011). This literature is impactful and applicable to understanding the physical
and psychological effects of the disease, but it does not go far enough toward
understanding how those with PD cope with the disease and live daily lives while trying
to manage symptoms.
Literature Search Strategy
I originally used the search term psoriatic disease because common sense seemed
to dictate that PD was the primary focus of my study and was therefore where the
literature search should begin. However, I soon discovered that this term was not at all
common within the formal literature. Ritchlin (2009) disclosed that psoriatic disease is a
fairly new term created to encompass both psoriasis and PsA. Based on this information,
I conducted searches on the two separate components of the disease, which resulted in
more information. Rarely did I find in existing research that information pertained to PD
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as a whole without acknowledging psoriasis as well. I also found that PsA was joined
with other forms of arthritis, most often rheumatoid arthritis. Although I do not discount
the impact that both of these diseases have, it should be noted that they are separate
diseases, and rheumatoid arthritis does not include the skin presentation of psoriasis. It is
important to remember that PsA goes hand in hand with psoriasis. One cannot have PsA
without having psoriasis (Boehncke & Menter, 2013; Liu et al., 2014).
Another search term that was beneficial was autoimmune diseases because PD
falls under that umbrella. Again, much of the research on this topic addressed the
efficacy of prescription drugs or how various autoimmune diseases compared to others
(Lesuis et al., 2012; Papoutsaki & Costanzo, 2013; Velez et al., 2012). Rarely was
information found that focused solely on the effects and presentation of PD as a whole.
This search was made even more difficult when only looking at females with PD. Few
studies were found differentiating between males and females in relation to PD, its
presentation, and treatment (Eder et al., 2012). However, through each of these search
steps, valid and appropriate information was gathered that helped to create a holistic view
of PD that particularly pertained to females.
The various searches used also helped to show a gap in the literature and how
exposing this gap and seeking to fill it could be beneficial to not only those living with
PD, but also the professionals relied upon to treat the disease. While the minimal data
that were available proved frustrating, this lack of information helped to validate that
current studies had not gone far enough or served to benefit all of those diagnosed with
PD. Instead, existing information had served to help a limited population of those
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affected, specifically those who sought to use pharmaceutical interventions (Boehncke &
Menter, 2013; Lesuis et al., 2012; Liu et al., 2014; Picchianti-Diamanti et al., 2010). The
missing populations in these studies were noticeably those whose members did not fit
into a neat and chosen demographic.
The primary databases used in researching the current literature included
PsycINFO, PsycARTICLES, and MEDLINE. I also sought out foundations such as the
National Psoriasis Foundation in the United States and the Psoriasis Association of the
United Kingdom. National health sites such as the National Health Service (NHS) in the
United Kingdom were used and the National Institutes of Health (NIH) of the United
States. I deliberately avoided sites that were sponsored by pharmaceutical interests to
maintain an objective view. In addition, sites that focused on natural remedies and cures
for PD were not used because their research was not documented in a way that could
withstand scientific rigor. These sources also proved worthy in locating information on
the following theories.
Theoretical Foundation
Choosing a treatment plan for an autoimmune disease is often an overwhelming
task. This choice comes with the understanding that the treatments are designed for
symptom management and will not cure the person of the autoimmune disease. Choosing
a treatment option involves people incorporating their belief system and way of life into
how they address their treatment. The theoretical framework for this study used selfefficacy and self-in-relation theory.
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Self-in-Relation Theory
Many of the theoretical frameworks previously used in PD research stemmed
from findings of studies with men as the subjects. Self-in-relation theory turns the focus
to women and involves the understanding that much of a woman’s “experience of self is
relational” (Surrey, 1998, p. 2). In contrast to theories that focus on individuality, self-inrelation theory reflects an understanding that women tend to see themselves in the
context of certain relationships. This theory emphasizes relationships in regard to one’s
experience and developmental process (Surrey, 1998).
Surrey sought to bring to attention to the notion that women need different
developmental milestones and terminology that match women’s development (Pilkinton,
2007). Self-in-relation theory takes out separation-individuation, which is the expected
achievement of adults becoming independent, and replaces it with relationshipdifferentiation. Mutual reciprocity specifically defines the “link between a girl and her
mother through their emotional sensitivity to one another” (Pilkinton, 2007, p. 28). The
need to care for others is often ingrained in a girl from an early age as she observes her
mother and seeks to emulate what her mother does. It becomes a constant, albeit normal,
struggle to balance one’s own needs with the needs of others.
This theory was originally proposed in the 1990s and is focused on women’s
psychological development (Pilkinton, 2007). The core of self-in-relation theory is the
idea that females do not go through developmental stages and life events in a vacuum.
Rather, these stages are experienced while the woman takes into account not only her
needs, but also the needs of others and how these needs can be balanced (Pilkinton,
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2007). Societal pressures along with expected norms may impact how a woman responds
to a given situation. Women are often seen as caretakers; for a woman, having to become
someone who needs care may not change the fact that one of her main goals is continuity
in the family structure.
Gilligan was one of the earliest feminist researchers to take an in-depth look at
women’s development (Pilkinton, 2007), and she brought to light a study conducted
based on Kohlberg’s moral development theory (Gilligan, 1982). In this study, an 11year-old boy and an 11-year-old girl were asked a moral question that centered on what a
husband should do if he could not afford the medicine his ill wife needed to survive. The
boy often had a clear and logical thought process concerning why the husband should
steal the medicine and how this choice might come with consequences, but the benefits
outweighed those consequences and were worth the risk. In contrast, the girl participant
often had difficulty coming up with an answer as she analyzed how each of the
relationships would be affected in the short term and the long term. The girl examined
the situation from a relational view as opposed to viewing each person as standing on his
or her own (Gilligan, 1982). To the girl participant, the decision was not one that only
the husband should make. Rather, the druggist should have seen the dire situation of the
wife and helped out. Boy and girl participants both perceived that some terms of
agreement would need to be reached, but where a boy used logic and law, a girl used
communication in relationships (Gilligan, 1982).
Transferring this idea to healthcare, it can be seen how pursuing the treatment
option as laid out by a physician is what a patient “should” do, in that the physician is the
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medical professional. However, from a relational perspective, a woman may be
concerned about other aspects of treatment recommendations, such as side effects of the
drugs prescribed, how the side effects could impact her relationships, and the cost of
these drugs. That is, her choices will have consequences for those close to her. A
woman diagnosed with PD may consider how her child’s lifestyle or quality of life will
be affected before she contemplates the personal effects of treatment options that are
available to her. Likewise, a woman may consider her career as she works to find a
balance between her job and her treatment options. The decision to pursue
nonpharmaceutical treatments may stem from a woman’s desire to balance self-care with
the care of her family and maintaining relationships that she holds dear.
Self-in-relation theory can inform studies on women and health care. Women
with PsA are more likely to experience medication side effects, have poorer quality of
life, and quit their medications compared to men in similar circumstances (Eder et al.,
2012). Self-in-relation theory allows medical professionals to see female patients as
wives, mothers, caregivers, employees, employers, or daughters (i.e., in the context of
their relationships and how these can impact how they decide on a treatment option).
Examining women in this relational context of disease management can allow for
greater clarity concerning how and why women choose certain treatment options. This
may then provide medical professionals insight that allows them to understand and
support these women. Medical professionals also need to use this insight when working
with these women in their treatment. Health care professionals and those who study
health-related quality of life (HRQOL) need to take into consideration that perhaps
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standard assessments such as the Dermatology Life Quality Index (DLQI) are sex-neutral
(Lusuis et al., 2012). Lusuis et al. (2012) even suggested that physicians may modify
their risk/benefit ratio, which could affect the treatment options that the physician offers.
The assessments currently used for those with PD are not specific enough to how women
experience the disease. Women’s responses on these assessments could negatively
impact their treatment options.
Self-Efficacy Theory
Self-efficacy theory is another vital framework to consider when studying chronic
diseases. Self-efficacy theory addresses a person’s confidence in his or her ability to
control his or her own motivation, behavior, and social environment (Bandura, 1997).
Bandura’s original theory of self-efficacy stemmed from the premise that outcome
expectations and efficacy expectations differ because an individual may very well know
that a certain behavior or course will lead to a specific outcome, yet he or she may doubt
his or her ability to carry out these behaviors or courses of action (Bandura, 1977). In
reference to health, patients may know that a healthy diet and regular exercise will
benefit their well being but may feel that they are unable to carry out these tasks on a
long-term basis. The possibility exists that if self-efficacy is high enough, an individual
will be able to implement the changes needed to improve his or her health.
A chronic disease such as PD can be seen as a threatening situation which,
according to Bandura’s theory, could affect a person’s self-efficacy due to his or her
emotional arousal. Bandura’s self-efficacy theory indicates that a small success for a
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person, such as seeing symptom reduction due to a dietary change, may then improve his
or her self-efficacy, leading him or her to try another alternative treatment option.
Perhaps women who seek to treat their PD without pharmaceutical intervention
have high self-efficacy, which leads them to believe that they are capable of making
necessary life changes to increase their health and confidently fight their PD. Viggers
and Caltabiano (2012) presented research that stressed the importance of acceptance and
self-efficacy on those with chronic diseases and their ability to adapt. Given the dire
diagnosis of PD and the knowledge that it is a chronic and potentially debilitating disease
may help solidify the need to take charge of one’s health while also being confident in
one’s own ability to choose the treatment path best suited for the individual, and not
necessarily the one prescribed by a medical professional.
Bandura’s theory can be broken down into two components: outcome expectancy
and efficacy expectation. Outcome expectancy is the person’s assumption that a specific
behavior will lead to a specified outcome, and efficacy expectation is the conviction of
the person that they can actually carry out this behavior (Bandura, 1977). Bandura’s two
components are applicable in the decision-making process one must undergo when
deciding on a treatment plan for a chronic disease, specifically PD. Self-efficacy can be
nurtured from achieving various successes in differing areas of life. A resilient selfefficacy that may benefit those with a chronic disease can be cultivated and strengthened
when one is pushed and overcomes obstacles (Bandura, 1997). One’s efficacy
expectations determine how much effort one will expend and persist in this effort in the
face of adversity or opposition (Bandura, 1977).
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Decisions are not made in a vacuum. A woman tends to take into consideration a
multitude of factors. The stakes are high when confronted with a chronic disease so the
incentive is great to put forth effort to successfully treat one’s diagnosis. Most people
may assume that listening to a medical professional’s advice and utilizing pharmaceutical
interventions may be the best course of action, yet women who choose not to utilize
pharmaceutical intervention may very well have a determined path of treatment that they
feel will lead to a better outcome or provide fewer risks than pharmaceutical treatment.
Understanding self-efficacy in women who treat their disease naturally can lead to an
understanding of the thought process and previous experiences of these women. It is
beneficial that before looking at treatments, one should first understand PD.
Psoriatic Disease
Psoriasis is a chronic inflammatory skin disease (Boehncke & Menter, 2013) that
results in those affected having varying skin presentations of the disease depending on
the type of psoriasis. Types of psoriasis include flexural, erythrodermic, pustular, guttate,
nail, and plaque. Plaque psoriasis is the most common form with an estimated 80-90% of
those with psoriasis having plaque psoriasis. Plaques are pink or red with silvery or
white scales and vary in size and location on the body (Papoutsaki & Costanzo, 2013).
These plaques are often the center of pharmaceutical advertisements for the treatment of
psoriasis.
Psoriatic arthritis (PsA) is a chronic disease that involves the inflammation of
areas around the joints and surrounding ligaments (Papoutsaki & Costanzo, 2013), along
with the connective tissue between tendons and bones (Liu et al., 2014). These areas

26
usually present with stiffness, pain, swelling, and tenderness (Papoutsaki & Constanzo,
2013). The duration, severity, and location can vary greatly (Liu et al., 2014). Some
discrepancy exists about the prerequisite of having psoriasis prior to being diagnosed
with PsA. There is a subset of those with PsA who have been diagnosed “sine psoriasis”
with a family history of psoriasis being enough (Scarpa et al., 2003).
The literature available circles the topic of PD without ever directly landing on
the topic. Studies were examined that specifically looked at those who utilized
alternative treatments for various health reasons. For example, a study conducted by Su
and Li (2011) sought to examine the trends in those who used complementary and
alternative medicine (CAM) from 2002-2007. While their data shed light on people
tending to use CAM due to restricted access to conventional care, it did not describe what
diagnoses the participants had that they were trying to address. Su and Li (2011) were
clear in identifying racial and ethnic differences, but there was no mention of gender
differences in those who are seeking CAM.
Astin’s study (1998) was slightly different in that it looked deeper into the
meaning of why people sought out alternative therapies for their health care and
specifically pointed to a gender difference. The reason given for minimizing gender
differences was that they were extremely close in that 41% of the female participants and
39% of the male participants reported using alternative health care (Astin, 1998),
although it was worth noting that this study did not include PD. The study by Astin
(1998) provided some insight, though, into why people may choose alternative health
which included more education, poorer health status, and having chronic pain.
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PD can involve chronic pain from arthritis, enthesitis, dactylitis, spondylitis,
psoriasis, and nail disease (Mease, 2012). This is an extensive list of symptoms to
attempt to control. Studies so far have looked at pharmaceutical interventions and their
effectiveness (Mease, 2012; Velez et al., 2012; Papoutsaki & Costanzo, 2013; PicchiantiDiamanti et al., 2010). This has left out those diagnosed with PD and how they treat their
disease naturally, and the possible effectiveness of their treatment option.
Numerous qualitative studies were found that sought to understand what it is like
to have a chronic condition, including psoriasis. Aujoulat, d’Hoore, and Deccache (2006)
analyzed over 55 articles focused on those with chronic conditions and patient
empowerment. Strikingly, the effectiveness of self-empowerment can be dependent on
the health care provider and him or her implementing a “patient-centered approach…that
acknowledges the patients’ experiences, priorities, and fears” (Aujoulat et al., 2006, p. 6).
Turning the focus onto the patient and validating his or her experiences, with PD and
living with PD, can help open a dialogue that allows for an honest discussion of treatment
options available and why a patient may consider one option over another.
Another qualitative study that focused on those with chronic pain looked at
resilience and coping strategies, and the psychological implications they had (Viggers &
Caltabiano, 2012). This Australian study found that resilience played a minor role in
mental well-being and that maladaptive strategies such as catastrophizing or taking on a
sick person role can increase depression, anxiety, and stress, whereas coping strategies,
whether positive or negative, can affect one’s HRQOL (Viggers & Caltabiano, 2012).
Another study looked at a chronic condition, though not specifically PD, and was a
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qualitative study aimed at understanding the strategies that women with fibromyalgia
utilize (Traska, Rutledge, Mouttapa, Weiss, & Aquino, 2011). Fibromyalgia and PD
have some similarities in that they can be “invisible diseases” where others may not be
aware of a person’s health diagnosis. Both currently have no cure, and can be difficult to
treat. Strategies were identified regarding how these women in the study coped with their
disease on a daily basis. Some of these strategies included planning, being selective
about activities, balance, environmental changes, and pushing themselves to accomplish
what they needed (Traska et al., 2011). The findings also suggested that a lack of support
from health care providers and other important people in their lives was difficult, but
being able to share their experiences with others with the same disease proved beneficial.
While no studies specifically focused on women with PD, a qualitative study on
those with psoriasis was conducted in 2009 by Magin et al. that resulted in the conclusion
that psychological sequelae in psoriasis were definitely an issue. While the psychological
issues may not be diagnosable, as they do not meet DSM-5 criteria, those feelings most
prominent were shame, anxiety, depression, low self-esteem, stigmatization, and being
self-conscious. Again, psoriasis can be unpredictable and unrelenting in its presentation.
One cannot negate the psychological impact this disease can have. Unfortunately, the
study acquired participants from a clinical setting so there is no way to decipher between
those who were being treated pharmaceutically and those who were treating only with
natural alternatives. Magin et al. (2009) suggested that a qualitative approach to this type
of study was better suited due to the complexities of the psychological construct. This
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study included psoriasis patients with a wide range of disease severity, allowing for better
insight into those with psoriasis with varying degrees of presentation (Magin et al., 2009).
Differences in Gender
Studies that have been conducted on PD alone have often combined males and
females (Boehncke & Mentor, 2013; Grozdev et al., 2012). While the studies that have
focused solely on PD have helped advance the knowledge of professionals of those living
with PD, they have merely scratched the surface. These studies did not differentiate
between genders. Eder et al. (2012) sought to understand the gender differences between
males and females when it came to the presentation and treatment of Psoriatic Arthritis
(PsA).
While PD tends to affect males and females equally, females have been shown to
have symptoms that differ from males, while also having differing outcomes when
treated with the same pharmaceutical interventions (Eder et al., 2012). Women tend to
have multiple joints affected at one time, while men usually present with few joints
affected. Females also tend to have poorer scores in patient-reported outcomes than
males (Eder et al., 2012). These findings were interesting as males have more severe
joint damage and women tend to endure a worse quality of life and limited functioning
(Eder et al., 2012).
That same study by Eder et al. (2012) showed that females tended to experience a
worse quality of life, worse fatigue, and more work disability than males with PD. Given
the physical and mental toll of those with PD, it may benefit these women to have
medical professionals who understand the reasoning behind how these women approach
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and decide on a treatment plan. If women are more likely to discontinue the
pharmaceutical route due to the negative physical, mental, and physical effects (Eder et
al., 2012), it is valuable to understand what they are doing to treat the disease and why
they have chosen that particular route. This same study suggested that social aspects
could impact the way women and men view their health (Eder et al., 2012). Further
understanding of the treatment options women utilize should be examined to ensure that
treatment options are available for a diverse population. Perhaps natural alternative
treatment options offer relief or fewer side effects.
Other studies conducted globally (Boehncke & Menter, 2013; Franks, Chapman,
Duberstein, & Jerant, 2009; Grozdev et al., 2012) have shown that quality of life is
negatively impacted by PD, thus there is a clear connection between mental and physical
well-being of those living with PD.
Quality of Life
Two of the ways that quality of life can be affected is with the unpredictability of
the disease and the finding of a treatment option that works. As with any treatment, there
is no guarantee that one treatment will work for everyone with that condition. An
example of how quality of life may impact women and their relationships is when they
are mothers. Remicaid® is an infusion drug used in the treatment of PD. Remicaid®
requires the patient to go to an infusion clinic for at least two hours to receive the
infusion about every 8 weeks with one dose costing between $1,300-$2,500 (Shiel,
2017). Based on these numbers a woman could potentially spend over 13 hours of her
life receiving the infusion, not taking into account travel time, wait time, or a possible
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reaction. The potential cost of over $13,000 depending on health insurance and co-pays
is also a real concern. Remicaid® also has the possible side effects of nausea, vomiting,
back pain, and headaches which could impede one’s ability to carry out his or her daily
responsibilities (Shiel, 2017) and negatively impact his or her quality of life. A woman
may opt out of this alternative due to time constraints and to ensure she is able to meet
her parenting obligations including transportation, meetings, activities, meals, and other
aspects of parenting that do not wait. Quality of life being impacted could lead to the
pursuit of less constraining options such as natural alternatives. There is the possibility
that she chooses a natural route for treatment so that she has fewer side effects and views
it as more cost effective, including time and money.
Another way quality of life is affected is dealing with the physical aspects of the
disease and being self-conscious, worrying about people noticing or commenting on the
disease and fearing that it may be contagious (Magine et al., 2009; Kotsis et al., 2012).
Magin, et al. (2009) defined the above aspects, as well as having an impaired self-image.
Activities such as swimming, trying on clothes, or going to the salon can become
battlegrounds in the mind of one with PD as these individuals need to be prepared for
comments, stares, or denial of services due to the presentation of their psoriasis.
Diagnosis of Psoriatic Disease
PsA is an inflammatory seronegative spondyloarthropathy that primarily affects
peripheral joints (Boehncke & Menter, 2013). This definition means that PsA belongs to
a family of chronic diseases that affects the joints. Symptoms of PsA are centered around
the joints, but can also affect the surrounding ligaments and tendons. These symptoms
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include stiffness, pain, swelling, and tenderness (Papoutsaki & Costanzo, 2013). These
symptoms can be irregular and spontaneous, leaving those diagnosed with a guessing
game of which joint or area of the body will be affected next and for how long. The
outside and the inside of the body are susceptible, leaving the person seemingly at the
mercy of the disease. The presentation of the disease can vary from person to person and
day to day. Ruling out rheumatoid arthritis by performing a blood test that specifically
tests for rheumatoid factor is one step used in the diagnosis of PsA. Should one present
with inflammation of joints, have psoriasis or a family history of psoriasis, and have
blood work that shows rheumatoid factor within normal range, he or she will often be
diagnosed with PsA, even though there are currently not universal criteria for the
diagnosis of PsA (Liu et al., 2014).
The Classification Criteria for Psoriatic Arthritis (CASPAR) is gaining
acceptance in various healthcare settings (Liu et al., 2012). The CASPAR consists of the
following five items being given certain point values: 1) current psoriasis or family
history of psoriasis or nail psoriasis, 2) absence of serum rheumatoid factor, 3) current or
prior history of dactylitis, which refers to the swelling and redness of a digit, 4)
radiographic evidence of periarticular bone, which means it is occurring around a joint,
and 5) new bone formation on x-rays of hands or feet (Velez et al., 2012).
Understanding the different symptoms and diagnosis of psoriasis and PsA is
important as it allows for those with psoriasis to know that they could be at risk for
developing PsA. Psoriasis is often the first to be diagnosed as the symptoms will usually
present ten years before PsA develops (Boehncke & Menter, 2013). Psoriasis can be
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diagnosed by a physical examination, a family history of psoriasis, and a general history
of the patient and if he or she has recently been sick, been on any different medications,
or has had a stressful life event. Psoriasis is often seen and managed in a family practice
environment (Magin et al., 2009). Those that practice in a family practice environment
need to understand that those diagnosed with psoriasis are susceptible to developing PsA,
given that up to 20% of those with psoriasis could develop PsA (Boehncke & Menter,
2013). Misdiagnosing or mistreating these symptoms can cause permanent damage if left
untreated, as PsA is progressive. Symptomology, diagnosis, and treatment are all aspects
of PD that are vital. Gender differences that arise in these areas need more attention.
PD has no signs of slowing down in progression or numbers of those diagnosed.
Thus, the job of the medical community, including mental health professionals, should be
to meet these patients where they are at the time of presentation. Unfortunately, much of
the current literature is vague on separating PD from rheumatoid arthritis, chronic pain,
or those with psoriasis. Other arthritis or chronic pain diagnoses do not have the added
skin symptoms that accompany PD. Psoriasis alone brings its own long-term impact on
physical and psychosocial health (Velez et al., 2012), but PD needs to be able to stand
alone in research given the impact it has on a person’s overall wellbeing.
Treatment Options
Treatment options can include pharmaceutical interventions, along with natural
options. Unfortunately, there is no treatment that is guaranteed to work for all symptoms
for any length of time on every person diagnosed with PD. The incurable aspect of the
disease can wreak havoc on those affected, along with the seeming unpredictability of the
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disease (Magin et al, 2009). The purpose of current treatment options is to minimize
symptoms. The treatment does not only have to work for these symptoms, but has to also
work in congruence with the responsibilities and relationships a woman has.
Pharmaceutical Options
Most pharmaceutical treatments seek to minimize or eliminate symptoms, which
may also negatively impact quality of life (Papoutaski & Costanzo, 2013). PD is a
chronic disease, whose course waxes and wanes. Any treatment options provided are for
symptom management, to minimize and slow joint deterioration, improve physical
abilities, and reduce the risk of death (Liu et al., 2014).
A brief list of pharmaceutical treatment options includes corticosteroids,
nonsteroidal anti-inflammatory drugs (NSAIDs), disease modifying antirheumatic drugs
(DMARDS), and anti-tumor necrosis factor agents (TNF inhibitor), with each of these
options carrying with them their own risks and side effects (Liu et al., 2014; Papoutsaki
& Costanzo, 2013). Corticosteroids and NSAIDS are the initial treatment for those
diagnosed with PD; however, they are meant to reduce symptoms and not slow progress.
Once these two options are not benefiting the patient a DMARD may be added to their
treatment (Liu et al., 2014).
Thus, a patient may be prescribed multiple, different medications for his or her
treatment of PD with no guarantee of results. Moving to a DMARD poses more health
risks, such as hepatotoxicity, which is liver damage that is drug induced. DMARDS are a
more ideal treatment for those with mild PsA as opposed to NSAIDS or corticoid
steroids, as these latter two treatment options will not slow down joint damage
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(Papoutsaki & Costanzo, 2013). Other DMARDS include Cyclosporine, Leflunomide,
and Sulfasalazine. Liu et al. (2014) noted that Cyclosporine has proven more effective
when combined with a biological therapy, adding yet another drug into the life of a
patient.
TNF inhibitors are known as biological therapies created to have more targeted
treatments, and while a noteworthy endeavor, these biological therapies carry their own
risks. Papoutsaki and Costanzo (2013) laid out clear requirements for those who are
prescribed biological therapies. The recommendations include a physical and history of
the patient needing to be conducted prior to starting treatment, along with liver function
tests, platelet counts, and tuberculosis testing (Papoutsaki & Costanzo, 2013). Patients
taking biological treatments need to be regularly monitored, and severe infections could
lead to the temporary or permanent discontinuation of the treatment. Those who watch
television may be familiar with a few common biological treatments that are regularly
advertised, such as Humira®, Enbrel®, Remicade®, and Stelara®. Most treatments for
PD suppress the immune system, which makes the patient more vulnerable to infection
and certain diseases, including cancer (Boehncke & Menter, 2013).
These treatment options can affect men and women differently, with studies
showing that anti-TNF agents are more likely to be discontinued earlier by females than
males due to possible less effectiveness in females than males (Eder et al., 2012).
European studies (Magin et al., 2009) have also shown that females may suffer a higher
number and worse side effects from these drugs than their male counterparts. A study
conducted in 2012 resulted in a noticeable difference in the males prescribed biological
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agents than females, while the females showed significantly higher scores on the DLQI
(Lesuis et al., 2012). The DLQI is an assessment on how the effect of the skin disease
affects one’s health related quality of life (HRQOL). The scores can range from 0-30
with the higher the score representing worse HRQOL (Lesuis et al., 2012). This
particular study showed that women have a greater score than men, by more than 10
points, even though men showed more psoriasis according to the Psoriasis Area and
Severity Scale (PASI). Thus, one needs to carefully weigh the costs and benefits of
living with the symptoms of the disease vs. the side effects of the drugs.
Side effects are most prevalent for those who treat their PD with anti-TNF-
agents. Anti-TNF- agents have significantly changed the treatment of PsA over the past
15 years as they have been shown to be effective in controlling symptoms and preventing
joint damage (Eder et al., 2012). However, women have been shown to quit this
treatment option earlier than males and have seen a more inferior response to treatment
than their male counterparts. Females tend to have more adverse side effects as well,
which contributes to early termination of the drug. Eder et al. (2012) suggest that sex
hormones and musculoskeletal performance could explain why females tend to not
respond as well as males do to anti-TNF- agents; however, no formal studies have been
found to support this idea.
Alternative Treatments
While not as popular or well-advertised, alternative treatment options do exist for
those with PD. Some of these treatment options include diet, supplements, exercise,
acupuncture, and lifestyle changes (Astin, 1998). Astin (1998) conducted a survey to
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help determine why patients use alternative medicine for their health care treatment. The
reasoning was not so much a negative concept of pharmaceutical intervention, rather, it
was because alternative treatments better aligned with certain patients’ values and beliefs.
Astin’s findings (1998) suggested that those seeking alternative treatments for their
healthcare appreciated the connection between mind, body, and spirit, and have had some
transformative event in their lives that has significantly changed their world view. While
this study did not specifically mention any type of medical condition, it is reasonable to
suggest that being diagnosed with a chronic, potentially life-altering disease such as PD
can be classified as a transformative event in one’s life. Astin (1998) also presented that
for those who have struggled with their health, it is their continuing suffering that has led
them to seek alternative treatments. Perhaps the suffering and the unpredictability of PD
can cause one to lose hope in treatment options or to continually be searching for a
treatment option that will reap the most benefits with the fewest amount of costs,
financial or otherwise.
Investigation into alternative medicine may give people with PD hope that
perhaps a cure exists. Yet when the patient goes to the doctor he or she will be told that it
is not curable, but may go into remission. The physician, however, can give no reasoning
as to how or why some people go into remission. Prescriptions will be discussed as a
way to improve symptoms associated with PD. This reasoning may work well for some
patients, but others may leave their doctor’s office less than satisfied. Further research is
needed in the area of alternative medicine to know more clearly its efficacy and possible
interactions with pharmaceutical interventions (Su & Li, 2011).
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Patients that choose alternative routes need to determine which alternative route
to take, what information to trust, and how much they are willing to invest in the process.
While alternative medicines may be cheaper than prescription drugs, many insurance
companies do not cover alternative treatments, such as diet protocols, supplements, or
therapies such as acupuncture. The patient now has to decide if the out-of-pocket cost is
worth the chance of becoming symptom free, with fewer side effects. The United States
Food and Drug Administration’s (FDA) oversight of prescription medications may make
them appear safer. Oversight of supplements and alternative medicine usually is less
stringent, and often results rely heavily on testimonials. While a debate can be made
about this subject in and of itself, the patient needs to decide for him/herself which option
better aligns with personal values and identity.
It can become a difficult choice when side effects are negatively impacting quality
of life when, ironically, they are expected to help improve one’s quality of life. While
pharmaceuticals may indeed slow the disease, the cost/benefit ratio regarding quality of
life is an important factor for patients to consider. The Australian study by Magin et al.
(2009) suggested that just the physical symptoms cannot be treated, rather an approach
that focuses on the patient and his or her coping and active involvement in treatment
decisions could help alleviate the negative psychological impact. These researchers
further noted that these results may not carry over to those that do not utilize
pharmaceutical interventions. Reaching out to those with PD who are not seen at a clinic
would give a clearer and more accurate picture of the range of treatments utilized by
those living with PD.
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The participants in the study by Magin et al. (2009) showed a theme of feeling a
lack of control over the disease. As they were recruited from doctor’s offices and thus
receiving pharmaceutical intervention, it begs the question of what psychological themes
are present in those who are treating their PD with natural alternative treatment options.
Examining quality of life in those with PD has shown repeatedly that quality of life is
negatively impacted (Boehncke & Menter, 2013; Eder et al., 2012; Grozdev et al., 2012).
Understanding decision-making and life experiences of those affected by PD has the
potential to benefit health professionals in the incorporation of therapies that meet the
needs of the patient. A general approach used on all patients as if they were the same just
because of a similar diagnosis may show to be an outdated approach.
Quality of Life
Males and females are shown to have the same rate for being diagnosed with PD,
yet women have been shown to suffer from a lower quality of life due to the disease
(Hammadi, 2016; Magin et al., 2009). PD is a physical disease that also comes with a
high risk of psychological comorbidity (Magin et al., 2009). Ample studies have shown
that chronic conditions affect one’s quality of life. However, few have sought to better
understand treatment options and if treatment options can impact quality of life (Eder et
al., 2012; Boehncke & Menter, 2013; Grozdev et al., 2012). Resiliency has also shown to
be an important factor when dealing with chronic pain (Viggers & Caltabiano, 2012);
however, chronic pain does not fully encompass the physical appearance that
accompanies a disease like PD. The unpredictability over psoriasis outbreaks and
knowing it is a chronic condition can be some of the most burdensome factors of the
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disease (Grozdev et al., 2012). The erratic presentation of PD is a complex area, as
having participants complete assessments while in a remission or during a severe
outbreak could affect how they respond.
PD is a disease that severely impacts many, if not all, areas of one’s life. While
males and females are affected at similar rates, treatment options have shown better
efficacy with males than females. Given there is currently no cure or proven prevention,
empowering females to live full and productive lives is vital. This starts with working to
understand women with the disease and how their perspectives, values, and beliefs can
influence interpretation, coping, and treatment choices of these women. The
psychological impact cannot be underestimated and should be part of the treatment plan.
Many psoriasis patients are seen in a family practice setting. Perhaps it is not enough to
seek specific medical professionals such as a general practitioner, dermatologist, and
rheumatologist for disease monitoring and management. It would likely be beneficial to
have psychological management and monitoring as well as part of routine care.
Medical professionals may need to adjust and work to better understand the
patients’ point of view and take into consideration the psychological impact of the
disease and the negative impact it can have on one’s life (Grozdev et al., 2012). While
the physical symptoms may be predominant, it cannot be the sole factor when
determining severity.
Viggers and Caltabiano (2012) began this endeavor with the examination of how
psychological functioning can impact adults with chronic pain. This study helped unite
mental and physical health and change the focus of care to caring for the whole person.
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The stance of the researchers was resiliency and how coping strategies impacted
psychological functioning on Australian adults with chronic pain (Viggers & Caltabiano,
2012). This begged the question about the participants and their choice of treatment.
Researchers need to take into consideration the multifaceted areas of disease and how
each of the physical and psychological areas need to be treated, and that it is just as
important not to overlook areas, such as the psychological impact of a disease (Grozdev
et al., 2012).
The use of alternative medicine is increasing in those with various health issues
including cancer, depression, chronic pain, and diabetes (Astin, 1998). A holistic
approach is starting to gain momentum as researchers continue to find significant
comorbidities in systemic inflammatory diseases like psoriasis (Velez et al., 2012).
Comorbidities can also include psychological diagnoses such as depression and anxiety,
so including mental health professionals on the treatment team creates a more holistic
approach (Magin et al., 2009). While PD is a chronic condition and is often accompanied
by chronic pain, it should not be under the same umbrella as other chronic diseases or
with a general term such as chronic pain (Kotis et al., 2012).
Studies exist looking at the effectiveness of pharmaceutical interventions and
effects on quality of life, but few, if any, studies look at quality of life for those who treat
their PD with natural alternative treatment options. Understanding the lived experience
of women who treat their PsA non-pharmaceutically could help various health
professionals reach out to this population and better understand and support their
treatment choices.
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PD and Mental Health
It has been shown that PD can negatively impact one’s quality of life (Papoutsaki
& Costanzo, 2013). The impact PD has on women especially can be multifaceted. Not
only are these women faced with a physical battle that is not always visible, there is also
a psychological battle. They must contend with a society that can be unforgiving of
physical flaws and where appearance can impact employment and appropriate
compensation (Stork, 2015). Research has shown that PD is associated with numerous
mental disorders and negatively impacts psychological and psychosocial functioning
(Ferreira et al., 2016; Kurd, Troxel, Crits, & Gelfand, 2010; Lee et al., 2010). An
important point is that PD is not a one-way street where this disease leads to an increase
in risk of mental disorders and increased stress. Rather, research has shown that stress
and depression can also greatly increase the risk of the development of PD (Leavitt,
2015).
Much of the research that is available has again centered on the use of
pharmacological intervention to help combat depression. While the purpose of these
treatments is to help restore serotonin levels, as well as decrease inflammation, there are
still risks involved. As mentioned earlier in this chapter, some medications available to
treat PD also block TNF-alpha’s disruption of serotonin, which has shown to improve
these patients’ mental functioning and moods (Leavitt, 2015). The drawback with this
approach is it is a costly treatment that women with PD may choose to avoid. As the
realization of the economic burden of PD is realized, policy makers need to understand
the various treatment options available and the holistic approach that needs to be taken in
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the treatment of PD (Lee et al., 2010). The concern was that this study largely focused on
pharmaceutical approaches to the treatment of PD in all its forms, whether physical or
psychological. Reasons for this avoidance were previously discussed in this chapter and
included financial cost, time burden, and lowered immune system. These studies have
shown what pharmacological interventions can be utilized to combat mental health
diagnoses such as depression, this then leaves out those who choose a nonpharmacological approach to treatment of their PD.
Stork (2015) reported that a key component in the mental health treatment of
those with PD is to reinstate some sense of control. PD is an unpredictable disease that
currently has no cure. These two factors can greatly impact the view a person has
pertaining to the life that is capable of being lived. While men are frequently taught to
solve their own problems and be independent, women are not always raised with this
sense of being in control of their future (Stork, 2015). The National Psoriasis Foundation
conducted a survey of almost 5,000 patients with psoriasis that showed 20% of these
women considered psoriasis a large problem in their everyday lives, as opposed to 12%
of men (Stork, 2015). Medical professionals should also educate women with PD on the
mental health impact of the disease and include it in the treatment plan (Leavitt, 2015). It
has been recommended that patients would be served best by a psychodermatologic
approach (Ferreira et al., 2016). The psychodermatologic approach seeks to emphasize
the mind-body relationship. Ferreira et al. (2016) conducted a systematic review to
examine the link between psoriasis and mental health disorders. While gender was not a
focus of this study, their results indicated several studies had shown females have a
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higher risk for secondary psychiatric comorbidities (Ferreira et al., 2016). Had they
included PsA in this study, perhaps a stronger link could have been made between
psychiatric conditions associated with PD. Regardless, the study suggested that the
treatment of either the physical or psychological aspect of psoriasis could impact the
other (Ferreira et al., 2016). Based on the psychodermatologic approach, PD should be
treated from a biopsychosocial model that treats the whole person (Leavitt, 2015). The
participants for this study included males and females who had been diagnosed with
psoriasis. The study did not clarify what percentage of these participants also had PsA.
Leavitt (2015) stressed that patients need to be aware of their moods and possible
changes, so that they can reach out for help in a timely manner. A study conducted in
2002 had two groups of participants with psoriasis (Leavitt, 2015). Leavitt noted that one
group completed six weeks of group therapy that taught coping skills, and strategies on
how to overcome negative thoughts, while the other group did not have this opportunity
(2015). It was found that after six months over 60% of the participants in the group
therapy had over 75% improvement in their psoriasis, compared to 23% in the control
group (Leavitt, 2015)! Stork explained the extent of women’s suffering, especially as
they cope with a society that highly values physical attractiveness. Women tend to adjust
their clothing choices based on the presentation of the psoriasis. This approach works
when the psoriasis is not visible on parts of the body not normally covered but is near
impossible on areas of the body such as face, neck, and hands that are normally visible.
A major component of mental health treatment is acceptance. Acceptance of a disease
that has no known cure and no predictable pattern.
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Acceptance can be a portion of mental health treatment. Approaches, such as
cognitive-behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT)
work to empower clients (Leavitt, 2015: Hulbert, Storey & Wilson, 2015). ACT works to
have clients develop valued directions that help drive their decision-making. Rather than
have clients work to eliminate negative thoughts, they work to accept them as just that,
thoughts (Hayes, 2006). The study by Hulbert et al. (2015) looked at the application of
ACT on patients diagnosed with cancer. Cancer is similar to PD in that it can be a lifethreatening and chronic condition. ACT seeks to increase the psychological flexibility of
a person, so as to improve their ability to cope in stressful situations (Hulbert et al.,
2015). This translates over into PD, as clients can make the switch to view their disease
as just that, a disease. PD is not their identity, but it is part of who they are. This concept
may not be an easy one to internalize due to the impact it may have. CBT is another
approach that has been useful in the empowerment of women (Stork, 2015). Teaching
coping strategies, such as mindfulness meditation, may help empower these women and
increase their psychological well-being (Leavitt, 2015). Mental health treatment could
may also be of benefit for those with a genetic predisposition to PD. Due to the
heightened risk of psychological comorbidity, researchers have suggested that patients
with a diagnosis of psoriasis be assessed for depression, anxiety, and suicidality (Kurd et
al., 2010). Learning coping skills and having strong emotional health would be beneficial
prior to the potential development of PD.
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Summary
Psoriasis affects an estimated 2-3% of the world population with a wide range of
6-30% of these individuals going on to develop PsA. While males and females are
equally afflicted with the chronic disease, it has been shown that presentation and effects
of the disease can vary widely between genders, with women experiencing lower quality
of life and less drug efficacy than their male counterparts. This chapter explained the
reasoning behind the organization of the research and the study. The purpose of this
research was to understand the lived experience of women diagnosed with PD and how
they decided on a non-pharmaceutical treatment plan. It was important to convey the
seriousness and complexities that go into this process with the understanding that these
are not numbers, rather they are mothers, partners, employees, bosses, teachers, and
others that the general public is likely to interact with daily.
Researchers have recently been able to specifically look at PD with its full clinical
presentation. Numerous studies have also looked at the psychological effects PD can
have (Eder et al., 2012: Liu et al., 2014). The statistics we do have bring vital points
about the psychological sequelae of PD, but it noticeably excludes those who are not
treating their disease with natural alternative treatment options and why they are choosing
to do so. The lack of resources on women who treat their PD with natural alternative
treatment options is unacceptable. The implications these findings can have on mental
health treatment are significant, given the impact PD has on psychological well-being.
Studies have shown the harsher side effects of current pharmaceutical treatment options
(Eder et al., 2012), yet little research has been conducted on these women and their
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experiences with choosing a non-pharmaceutical path. It is also lacking a patientcentered approach to patients in an effort to reduce psychological co-morbidity (Magin et
al., 2009). Velez et al., (2012) suggested further study on the impact of a holistic
approach to help improve quality of life and health care efficiency. Understanding the
lived experience of these women with PD who treat naturally helps to better understand
this concept. Given the psychological impact of PD, mental health professionals need to
understand the complexities and psychological impact of PD. The research method
described in Chapter 3 will be used to understand the lived experiences of these women
who choose to treat their PD with natural and alternative treatments. This
phenomenological study consisted of interviews with women who have been diagnosed
with PD and who are currently not utilizing pharmaceutical interventions. The complete
layout of the research and design, along with ethical considerations are described next.
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Chapter 3: Research Methodology
Introduction
The examination of the decision-making processes of women with PD who have
decided on a nonpharmaceutical treatment plan may allow researchers and healthcare
providers to better connect with these clients in a supportive role. Previous studies have
highlighted the lower quality of life in people diagnosed with PD, but it is yet to be
determined how those diagnosed with PD come to the decision of how they treat their
disease and why they choose a specific course, specifically alternative treatments
(Boehncke & Menter, 2013; Eder et al., 2012; Mease, 2012). This study was conducted
using a qualitative approach, specifically transcendental phenomenological research.
This chapter details the design of the study, including why it was chosen, how it was
used, the role of the researcher, and ethical considerations.
Research Design and Rationale
The methodology for this study was qualitative because the primary purpose was
to explicate the meaning and essence of lived experience pertaining to a specific
phenomenon (Christensen, Johnson, & Turner, 2010). Qualitative researchers not only
seek to understand the lived experience of a person regarding a specific phenomenon, but
also attempt to make sense of the meaning that this phenomenon brings to the person
(Creswell, 2013). The purpose of this study was to closely examine the decision-making
process of women with PD who have chosen to treat their disease with natural alternative
treatment. The research questions for this study were able to be more accurately
examined and answered through a qualitative approach.
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Feminist research aligns well with qualitative research. As discussed in Chapter
2, self-in-relation theory was one of the frameworks used for this study due to this theory
taking into account how women view the world, with the notion that much of their view
is relational. Feminist researchers seek to enhance the voice of women by understanding
that all descriptions of experience and reality are made from a particular standpoint
(Willig & Stanton-Rogers, 2011). This stance coincides well with phenomenology and
with my aims as the researcher in this study. It was my intent to be able to convey to the
audience the experiences of these individuals from their unique perspectives.
Another advantage of phenomenology is that there exists a general understanding
that a relationship exists between the mind and the world (Howell, 2017). Using
phenomenology, I sought out the description of the lived experiences of these women in
how they decided on a treatment plan that did not include pharmaceutical interventions.
With such little existing research on the topic, this qualitative approach was intended to
create a foundation that could help lead researchers to better understand this decisionmaking process. Further study on the topic will allow for more attention on the treatment
of not only the disease, but also the person who has the disease.
Phenomenology was chosen over other qualitative approaches because
phenomenology is used to describe lived experiences. Bloor and Wood (2011) described
how Amedio Giorgi stressed that the role of psychological researchers was to gather
specific descriptions of a specific event and then look for the meanings of these
phenomena. Within phenomenology, it is important for the researcher to ask questions
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that produce information as to what the experience of the phenomenon was like for the
person who encountered it (Bloor & Wood, 2011).
Phenomenological research involves asking participants open-ended questions in
an attempt to elicit descriptions of specific events; in this study, I sought information on
choosing treatment options pertaining to PD. From this information, I was able to
describe the structure of the experiences through reflection and interpretation
(Moustakas, 1994). The goal of this process was to determine the meaning of these
experiences and to develop more general meanings. This methodology allowed for the
participants to describe their experiences in their own words. Open-ended questions
made it possible for the participants to verbalize their experiences from their
perspectives.
With limited knowledge of women diagnosed with PD who treat their disease
naturally, phenomenological research assisted in laying a solid foundation in developing
themes and meanings from these participants’ stories. The foundation will potentially
lead to further research in this area and help health professionals develop a greater
understanding of this population and how best to serve them. I was able to generalize
and present the data collected in a way that encouraged readers to become emotionally
engaged (Bloor & Wood, 2011). Below are the research questions that were the focus of
this study.
RQ1. What is the lived experience of the decision-making process for women
with PD who choose alternative or complementary interventions as
opposed to pharmaceutical interventions?
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RQ2. How do they feel about the treatment decision they made, and what
benefits have they noticed?
Role of the Researcher
Using a qualitative approach required me to first seek to understand the workings
and purposes of the qualitative method. Qualitative research requires the researcher to
have self-knowledge and awareness. Perhaps the most challenging aspect of qualitative
research is that, as Janesick (2011) observed, in order for participants to trust the
researcher, the researcher needs to trust him- or herself. Janesick went onto say that the
researcher then must have “solid knowledge of the self” (2011, p. 4). This is a powerful
idea in that it suggests that it is not just the interviewing of others that is important, but
also the relationship of the researcher with herself. Each of the participants in this study
shared a common thread, yet each participant brought her own perspective, experiences,
and self-awareness.
My role as the researcher was decided after much consideration. Husserl, a
German philosopher who is credited with founding phenomenology, emphasized the
importance of first-person perspectives (Howell, 2017). It was my intent to be able to
present the experiences of women who had been diagnosed with PD and had to decide
what course of treatment to pursue and what this process was like for them. It should be
noted that I have been diagnosed with PD and have also experienced and continue to
experience the process of deciding on a treatment plan. Phenomenology posits that the
researcher should work to bracket his or her experience so that the data collected will be
viewed from a fresh perspective (Creswell, 2013).
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While it would be ideal to have only this fresh perspective, all people experience
events in accordance with their own beliefs and past experiences. Assuming a
phenomenological attitude requires the researcher to bracket his or her own beliefs and
experiences. The researcher also works to take the experience as a phenomenon for the
person, not necessarily a reality in the world (Giorgi & Giorgi, 2011). These are two
heavy expectations to have of any researcher, yet by reaching for these ideal standards, a
researcher may stand back from his or her understanding and interpretation (Ladkin,
2014). The importance of the researcher viewing data collection from this vantage point
is that it has the potential of enabling the researcher to hear other experiences in a way
that is new, allowing for various perspectives to be taken.
I was constantly vigilant in my awareness of my own biases and experiences and
how these had been handled throughout the research process. I disclosed my diagnosis
and treatment choice to each participant. My diagnosis of PD brought a wealth of
knowledge to the table, in that I was able to empathize with those being interviewed
because I had experienced similar struggles, feelings, and emotions. One is never free
from one’s own perceptions and past experiences; this can hamper one’s efforts to fully
understanding another’s experience (Howell, 2017). However, it is possible to be aware
of one’s own experiences and perceptions while also seeking to understand another’s.
Methodology
Participation Selection Logic
The population that was used for this study consisted of women who had been
diagnosed with PD and were currently using nonpharmaceutical treatment options. The
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purpose of criterion sampling was to select cases that met a specific set of criteria. Using
criterion sampling for this research ensured that those interviewed all had the same
general background. The criteria were not extensive. However, the criteria were meant
to ensure that the data collected came from sources that were similar.
Four selection criteria were applied. The first was that the participant needed to
be a biological female who identified as a female, which helped to ensure that the
participants were similar in gender and gender identification. The second criterion was
that all participants needed to have been diagnosed with PD by a physician. Each
participant had experienced psoriasis and symptoms of PsA. The literature described the
varying symptoms that can be experienced by those with PsA, as well as the degree of
severity and the differing presentations of psoriasis (Boehncke & Menter, 2013; Liu et
al., 2014; Papoutsaki & Costanzo, 2013). I was concerned only that the participants had
been diagnosed with PD. The various presentations of the disease were described but
were not part of the criterion. The next criterion was that the participants had been using
only nonpharmaceutical approaches for at least 6 months. This time limit helped give
some stability to the participants. Those who had recently gone off of medications might
still have felt effects that may have inhibited accurate insight. Ensuring that timeframe
also allowed for the participants to have a chance to better gauge their perception of their
choice. The last criterion was that the participant spoke and understood English and had
access to the Internet and a computer. I applied these criteria solely for the purpose of
accurate data and accessible participants.
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One criterion that was not chosen was that the participant would only have used
nonpharmaceutical treatment options. This criterion would have prohibited data from
being gathered from those who may have chosen a pharmaceutical route at some point in
their treatment and brought further insight into their choosing of non-pharmaceutical
interventions. Another criterion that was eliminated was age. While I was seeking a
lived experience of a similar population, the ideal study also sought to be diverse in
allowing for varying perspectives. This same reasoning was also used when eliminating
race, ethnicity, and country of residence. The far reach of the Internet allows for those
across the globe who share the same experiences to be able to connect. The common
experience for this study was that women who had been diagnosed with PD were able to
share how they came to decide to treat their disease nonpharmaceutically.
Setting and Sample
The participants were located through two Facebook support groups for those
with PD. One of the support groups had a primary focus on being supportive to all those
with PD and the daily struggles of this disease, along with peer advice concerning
medications and treatments. The other Facebook group focused on the nutritional aspect
of a person’s health while trying to navigate life with PD. It was my intent that a diverse
sample be sought. Online support groups allowed me to reach individuals with PD who
might not have been accessible at medical clinics. After the approval of the site
administrators, an advertisement was posted that requested participants for the study.
The advertisement included the purpose of the study, the requirements of being a
participant, and a small biography of the researcher (see Appendix A). Those who
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responded to the advertisement were given a brief description of the study and asked to
sign an informed consent.
The number of those to be studied varied, as the research concluded when the data
were saturated. Qualitative research does not place requirements on the number of
participants, with a general rule being to interview participants until the data becomes
repetitious so that no new themes are emerging. For this study, I sought to acquire 20
potential participants who met the criteria and were willing and able to be interviewed.
The participants were interviewed by their availability. Even though the target sample
was 10 participants, saturation was reached after seven participants. It was
communicated via electronic mail that should a participant be unable to complete an
interview within a given timeframe, the participant would be removed from the study.
This only happened in one instance.
Instrumentation
Within qualitative research, the researcher is often a vital instrument, so ensuring
that the researcher is well-prepared is invaluable. The researcher carries the
responsibility of recruiting participants, collecting data, analyzing data, and reaching
conclusions. Organization is important so that there is a clear protocol that will be
followed and can be replicated if needed. I started by preparing an open-ended interview
that included all questions to be asked of all participants (see Appendix C). Patton (2002)
clearly stated that the quality of the information garnered relies heavily on the
interviewer.
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The interviews that I conducted were audio recorded and were then transferred to
my personal computer. My computer is password protected, and the data have been
stored in a file that is discrete. The information has been stored using a numbering
system so that participant names are not attached to the data. The data will be stored for
7 years.
Data Collection and Explication
The data collected for this study consisted of one-on-one open-ended interviews.
Consistent open-ended interviews allow for a specific set of questions, which is
beneficial for a few reasons. First, consistent questions ensure that the same questions
are asked of each participant, which allows for easier inspection by those who will use
the study. Next, consistent questions help to ensure a highly-focused interview and the
most efficient use of time. Also, the analysis was easier to complete afterward as
responses were easier to find and compare (Patton, 2002). The consistent questions also
helped to ensure that the necessary questions were asked. Open-ended questions were
asked with the exact wording and sequence of questions being predetermined. I used my
discretion to ask follow-up questions when I determined that additional information
would be beneficial to the research.
Some of the questions asked were as follows: How long have you been diagnosed
with PD? How long did it take you to get diagnosed, once you realized something was
wrong with your health? What treatment options were presented to you after you were
diagnosed? How did you become aware that treatment options besides pharmaceutical
interventions were available? How do you stay current on what treatment options are
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available to for PD? What was your thought process when deciding that pharmaceutical
treatment was not what you wanted? What were the contributing factors in the decision?
How do you feel about the choice you made? Did you discuss your decision with your
doctor? How did your doctor respond? Do you regularly go to a medical doctor for
disease management? Do you see any other medical professionals, such as a naturopathic
physician?
That being said, bracketing was used so that I could put aside my experiences and
approach the participants’ experiences with a fresh perspective. Bracketing, or epoche,
which is an ancient Greek term, is a suspension of judgement (Howell, 2017). This is an
important aspect of phenomenology. Epoche, which can also be referred to as
transcendental phenomenology, entails looking at these lived experiences just as they are,
without interference.
Explication
Explication was used in place of the word analysis because explication has the
connotation of researching a phenomenon while keeping the context whole, whereas
analysis has the implication of seeking to break the data apart (Groenewald, 2004).
Explication of the data was conducted using the following five steps: bracketing and
phenomenological reduction, delineating units of meaning, clustering of units of meaning
to form themes, summarizing each interview, and extracting general and unique themes
from all interviews and making a composite summary.
Bracketing, as previously mentioned, is a deliberate step in which the researcher
sets aside his or her own experiences and takes the data as being new information, with
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no opinion being formed. Groenwald (2004) suggested that listening to interview
recordings repeatedly to become familiar with the data can help one embrace the
participant’s experience. These interviews were transcribed on my personal computer.
Delineating units of meaning involves separating the information that specifically
showcases the phenomenon. This stage was used in conjunction with bracketing as I
needed to work to see the data without my perceptions and draw out what was important
based on the data and the research purpose.
The next step, clustering of units of meaning to form themes, requires the
researcher to use his or her “artistic judgment” (Groenwald, 2004, p. 19). The clusters
were created by me grouping the units of meaning together and the researcher identifying
significant topics. NVivo was not needed for this step. Each summarized interview
included the themes discovered in the data. This step involved reaching out to the
participants to see if they were interested in reviewing the summary to ensure the
participant’s information was correctly conveyed. This step helped ensure validity
(Groenwald, 2004).
The last step called for me to look for the common themes as well as the
individual themes that emerged. This required me to be familiar enough with the data to
be able to separate common themes if differences occur. The above steps revealed what
was gleaned from the data. These steps brought these everyday descriptions into a
scientific language that was able to lay the foundation for theorizing, no matter how small
(Groenwald, 2004).
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Issues of Trustworthiness
Having research that is valid was my intent. Qualitative methodologies have
criteria that researchers follow to ensure that the issue of trustworthiness is addressed.
These criteria are credibility, transferability, dependability, and confirmability (Morrow,
2005). Credibility involves the researcher acquiring thick descriptions from the
participants that not only include the phenomenon, but the context and culture as well
(Morrow, 2005). Addressing credibility requires the researcher to take time with the
participant during the interview and to check back with the participant afterwards.
Sharing the summary of the interview with the participant allowed me to hear feedback
from the participants and ensure that the participant’s experiences were conveyed
accurately. A potential drawback was that the participant may not be willing to
participate or available at this step. Fortunately, only one participant did not respond to
the summary, As previously mentioned, it benefited me that I was familiar with the data,
which aided in me using my judgement to understand the participant’s experience.
Transferability can prove to be a difficult task as it is not same as generalizability,
as known in quantitative studies. Rather, transferability is achieved with the researcher
being transparent and open about the research. I provided the information on myself as
the instrument along with context, processes, participants, and relationships, which
allowed the reader to decide how these findings can be transferred to a more general
population (Morrow, 2005). It was not the intent that these findings will be generalized
to other populations or settings, nor should the reader assume this.
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Dependability can be accomplished by the researcher documenting the process,
from the designs to data collection to analysis. Morrow (2005) stressed the researcher
use a log to keep detailed records of activities, processes, influences, emerging themes,
categories, and analysis notes. I had a notebook used to document dates and thoughts on
the research and the steps taken. This allowed for others to fully understand this research
and enable them to repeat this study if they should choose to do so. The last criterion is
confirmability. Confirmability is based on the premise that research is never fully
objective (Morrow, 2005). However, there are ways to address this issue. Reflexivity
was used, as I disclosed my biases and necessary experiences that were mine. Ensuring
confirmability was an ongoing process of keeping detailed records and constantly being
aware of personal biases at all stages of the research. It is through these four areas that
this research maintained high standards. Trustworthiness can be a constant influence, as
well as ethics, which will be described next.
Ethical Procedures
The purpose of this study could have unintentionally led to the participants
experiencing reactions that they may have had difficulty coping with. The researcher
took this risk seriously and sought to have the participants be as educated as possible
about the research and what it entailed. This began with recruiting participants in a
respectful and transparent manner. The Facebook pages previously mentioned as sources
for locating participants have strict guidelines for soliciting. I prepared a document to be
sent to the page administrators detailing the researcher and my study (see Appendix A).
Once these administrators agreed, an agreed upon post was created and posted for
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potential participants (see Appendix A). Given the anonymity of the internet, private
messages were encouraged for initial contact with phone number exchanges to follow.
Prior to the interview participants were able to ask any questions they may have
had for me. I explained the research to the participants prior to them signing the
informed consent form. Participants were informed that they may opt out of the research
at any time and for any reason. Participants were then asked in the interview how they
were feeling and were made aware prior that should they begin to feel intense emotions
to notify the interviewer. If a situation arose where the participant felt she needed to
speak to a mental health professional, I would have directed the participant to mental
health professionals in the area in which she lives, if she was not currently in therapy
with a mental health professional. Fortunately, this was not a concern for any participant
involved in this study.
Confidentiality was treated with the highest regard. Each participant was
assigned a number, and that number was how they were identified in the research, as well
as how the interviews were identified. I know the identities of the participants, but will
not share the information without the participant’s consent. The participant was informed
of this confidentiality prior to the interview as well as how her data were to be stored and
used. The participants were informed that data was to be stored on the researcher’s
personal computer. They were also made aware that my personal computer is password
protected and that the information will be stored using numerical identifiers, rather than
the participants’ names. Participants were also informed that per APA guidelines, data
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will be stored for 7 years. Participants had until the follow-up communication to pull out
of the research. None of the participants chose to be removed from the study.
The researcher is the sole person with the number and identity key. That being
said, those with access to the raw data include myself, dissertation committee, and only
necessary Walden staff, such as the IRB. Raw data will be destroyed by being deleted
from my personal laptop after seven years. Participants were provided the option of
being notified when their data are to be deleted. All participants denied this option.
Summary
This chapter laid out how the research was conducted, stored, and analyzed.
Information was also provided on how the participants would be recruited, informed, and
interviewed. The researcher as the instrument was carefully described in hopes of
conveying the importance of being that instrument and the necessary responsibilities.
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Chapter 4: Results
The purpose of this study was to examine the lived experience of women with PD
who had chosen to treat their disease with natural alternatives as opposed to
pharmaceutical interventions. Through this research, I sought to fill a gap in the literature
on how women make decisions in regard to treatment of PD. Another purpose of the
study was to provide greater understanding of this population, which could be beneficial
not only to women, but also to practitioners who work with them. The research questions
were the following:
RQ1. What is the lived experience of women with PD who choose alternative or
complementary interventions as opposed to pharmaceutical interventions?
RQ2. How do they feel about the treatment decision they made, and what
benefits have they noticed?
In this chapter, I examine the setting of the study and how participants were
recruited. I look at how the participants differed in how they were chosen and their
demographics. Participant information is provided, including the number of participants,
duration of interviews, and variations from the original research plan. I also explore the
four areas of trustworthiness mentioned in Chapter 3: credibility, transferability,
dependability, and confirmability. Finally, I present the findings of the research and
address saturation, nonconforming data, and how I approached each research question.
Setting
The original research plan called for the use of two Facebook support groups for
PD to locate participants. While three Facebook support groups were contacted, only one
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approved the request. The only group to approve the advertisement was a site that
promoted natural alternative PD treatments. Although all participants were recruited
from one Facebook group, it was confirmed that participants in this group also belonged
to other Facebook support groups, including those through which I had unsuccessfully
sought permission to recruit participants. No reason was provided for the denial of the
advertisement on the two other Facebook groups.
The administrator for the cooperating Facebook group was eager to help by
spreading word of the study. The study was reintroduced two more times after an
original posting to acquire more participants. Previous participants commented about the
study on the group’s page and encouraged others to participate. The administrator of the
Facebook page forwarded all questions regarding the study to me and provided my
contact information to those who expressed interest.
Demographics
To ensure participant anonymity due to the number of members in the cooperating
Facebook group, I asked only broad demographic questions. Of the seven participants,
one was from the United Kingdom, one was from Canada, and five were from the United
States. Of the five participants from the United States, one was from the East Coast, and
four were located in the Western region of the United States. One participant reported
being on disability due to her PD. Six of the seven participants reported having children,
and one of those participants had three children under the age of 7. Two of the
participants reported being married. One participant stated that she was the primary
caregiver for her elderly parents.
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Data Collection
Each participant completed the interview questions as laid out in Chapter 3. The
seven interviews each lasted approximately 30 minutes. The interviews were recorded
using a personal recording device. The interviews were then uploaded onto my
computer, where they were labeled with “Participant 1,” “Participant 2,” and so forth.
The data were then transcribed using Rev, an online transcription service. I completed
two of the interviews using FaceTime and the other five interviews by phone. The
original plan was to use video chat; however, this proved difficult due to issues of
technology and convenience.
While adhering to the protocol presented in Chapter 3, I found myself frequently
checking my emotions in response to what the participants shared. I frequently checked
in with myself to ensure that I maintained the role of researcher throughout the duration
of each interview. In addition, three of the participants inquired about my treatment
method and diagnosis. While I answered directly and honestly, I felt pangs of
inadequacy and a need to defend my current treatment options.
The consistent presentation of open-ended questions proved effective and allowed
the scope of the study to remain in focus. Due to the vast experiences of those affected
by PD, it would have been easy to slip into countless conversations about various aspects
of the disease. The interview questions helped to align my focus to where it needed to
be. It was also important that the analysis be clear, and that I was able to find and
compare themes and data with ease (Patton, 2002). I used my discretion to ask follow-up
questions as needed. This helped to ensure that participants provided the necessary
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information and that I understood what they expressed. At times, participants became
caught up in a topic and needed to be guided back on track.
Data Analysis
The questions that I asked included the following: How long have you been
diagnosed with PD? How long did it take you to get diagnosed, once you realized
something was wrong with your health? What treatment options were presented to you
after you were diagnosed? How did you become aware that treatment options besides
pharmaceutical interventions were available? How do you stay current on what treatment
options are available for PD? What was your thought process when deciding that
pharmaceutical treatment was not what you wanted? What were the contributing factors
in the decision? How do you feel about the choice you made? Did you discuss your
decision with your doctor? How did your doctor respond? Do you regularly go to a
medical doctor for disease management? Do you see any other medical professionals,
such as a naturopathic physician?
Bracketing was used so that I could put aside my experiences and approach the
participants’ experiences with a fresh perspective. Bracketing, also known as epoche,
involves suspension of judgment (Howell, 2017) and is an important aspect of
phenomenology. Through epoche, researchers attempt to look at lived experiences just as
they are, without interference from biases.
As I went through the data, themes began to emerge. First, there was a common
feeling of self-empowerment among the participants. While not always able to identify
the feeling, the participants noted a “gut feeling” that there was more that they could do
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aside from taking pharmaceuticals. Participant 2 noted, “I really in my heart felt that it
was the wrong thing to be taking for my body.” She made this statement after 1 month of
trying a pharmaceutical to address her PD. Many of the participants had been health
conscious prior to their diagnosis and had used alternative treatments for other
conditions. Participant 4 reported how her refusal to take the pharmaceutical route was
the first time she had gone against medical advice. On the other hand, Participant 5
frequently disclosed her distrust of medical professionals and their lack of knowledge in
regard to autoimmune diseases. Regardless of their stance toward medical professionals,
all participants researched other alternatives and sought to engage in a treatment plan in
which they could feel confident. Even when they started treatment plans, they continued
to assess and modify their treatment as they went along.
Another theme that emerged from the research was medical professionals’ first
line of treatment being a pharmaceutical intervention. None of the participants reported
that their medical professionals had broached the subject of alternative treatments or
dietary changes. Participants reported that although their healthcare providers might not
have been against dietary changes, they did not see such changes as viable treatment for
PD. Participant 4’s rheumatologist clearly stated to her that she would see her in 6
months, as if the dietary changes she was making would not be beneficial to her.
Participant 7 reported that it was difficult for her to maintain medical appointments due to
her not accepting pharmaceutical treatment options.
An alarming finding across the participants was how many ran the risk of no
longer being under the care of a rheumatologist because of their treatment options. It
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became apparent in the data that medical professionals had little to offer patients who
decided against pharmaceutical interventions. A few of the participants simply attended
appointments as “check-ins” so that they would not lose their providers. A common fear
among the participants was the possible progression of PD. Very few had completely
sworn off pharmaceutical interventions; rather, they wanted to pursue such interventions
only as a last resort.
Many of the participants had sought the services of alternative medical
professionals, such as naturopaths and acupuncturists. The participants were methodical
in their research on alternative treatments and in seeking alternative sources of reputable
help. They were willing to try various alternatives. One participant pursued a Chinese
formula. She stated Chinese formulas are supplements and herbs chosen specifically for
the individual. All participants made dietary changes that involved eliminating foods that
they thought might trigger their symptoms. Participant 3 noted that she wanted not just to
eliminate trigger foods, but also to incorporate anti-inflammatory foods. Participants
were in tune with their bodies and noticed small changes in pain and swelling.
Participant 3 was specific about the foods that she had eliminated; most participants were
able to identify which foods led to certain symptoms.
No two participants had the exact same treatment plan. While all participants also
incorporated supplements, they all had their own regimens. Just as with their diets, they
adjusted their supplements as needed and paid close attention to their bodies.
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Evidence of Trustworthiness
Qualitative methodologies involve criteria that researchers attempt to meet to
ensure that their work is trustworthy. These criteria are credibility, transferability,
dependability, and confirmability (Morrow, 2005).
Credibility involves the researcher acquiring thick descriptions from participants
that include not only the phenomenon of interest, but also the context and culture
(Morrow, 2005). I gathered such descriptions in the interviews as clients discussed
where they were located and what treatment looked like in their communities. For
example, Participant 4 discussed how widespread alternative treatments were in Oregon
where she lived. Participant 5 referred to the area she lived in as a “killing field.”
Addressing credibility also requires a researcher to take time with participants
during interviews and to check back with them afterward. Sharing a summary of an
interview with a participant allows a researcher to hear feedback from the participant and
ensure that the participant’s experiences are conveyed accurately. I wrote summaries to
address the research questions as well as other areas that I thought were pertinent to the
participants’ experiences. I emailed each participant a copy of the summary, but only one
participant asked that changes be made. Four participants did not respond to my email. I
sought to become familiar with the data by listening to the interviews numerous times to
convey the participants’ experiences.
Transferability can prove difficult to achieve. It is not the same as
generalizability, a term used in quantitative studies. Rather, transferability is achieved by
researchers being transparent and open about their research. In order to offer
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transparency, researchers provide information on themselves as the instruments in their
research, along with appropriate information on the research context, processes,
participants, and relationships. This information allows readers to decide how the
findings may be transferred to a more general population (Morrow, 2005). It is not my
intent that these findings be generalized to other populations or settings.
There were numerous times throughout the interviews that I felt connected to my
participants. The participants shared many relatable experiences with me, and I
sometimes found myself struggling to remain objective. The stories about which I found
it perhaps the most difficult to separate my personal experiences were those in which
participants described feeling dismissed by a medical provider. Each time a participant
shared an experience of not feeling supported by a medical provider, I went back to my
own experience of being dismissed. Women with autoimmune diseases sometimes report
symptoms that do not make sense to the medical community. When a medical provider is
able to make a diagnosis and the patient does not agree with the treatment options, the
interaction may not go well. However, the strength of these participants was evident as
they continued to research treatment options and determine for themselves their best
course of action.
Dependability can be accomplished by a researcher documenting the process of
research, from design to data collection to analysis. Morrow (2005) stressed the need for
a researcher to use a log to keep detailed records of activities, processes, influences,
emerging themes, categories, and analysis notes. I used a notebook for documenting
dates and thoughts on the research and the steps being taken. Notes were also taken on
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the interview forms. I listed dates, emotions felt, new questions raised, and developing
themes. Referring back to these notes was beneficial, in that I was able to see clearly
how I had conducted the research and what my thought process had been. This
information may allow for others to better understand this research and enable them to
repeat this study if they choose to do so.
The last criterion, confirmability, is based on the premise that research is never
fully objective (Morrow, 2005). To address this issue, I used reflexivity, disclosing my
biases and experiences. I disclosed my diagnosis of PD and treatment options when
asked by participants. Four participants inquired about my treatment options. Only one
participant responded in a way that made me question my qualifications for conducting
research on a population to which I did not belong. However, this discomfort was short
lived, as I went back through my research and considered why I had sought this topic out
initially. Ensuring confirmability was an ongoing process of keeping detailed records
and constantly being aware of personal biases at all stages of the research. It required me
to frequently check in with myself and spend time understanding my biases while seeking
to understand the lived experiences of the participants.
Results
RQ1. What is the lived experience for women with PD who choose alternative
or complementary interventions as opposed to pharmaceutical
interventions?
The information provided by the participants indicated that these women felt
capable of taking control of their health. There was a sense of resolve on the part of the
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participants in the choice to pursue natural treatment options and forgo pharmaceutical
interventions. Participant 4 referred to herself as her own “advocate,” as did Participant
5. Participant 5 stated she was “angry” with Western medicine and her experiences with
medical professionals. She noted that a previous health issue had led to a “severe healing
crisis.” This previous experience had helped give her the confidence that she could take
control of her treatment of PD. Others disclosed a “gut feeling” that pharmaceutical
options were not for them. While many of the participants reported not feeling supported
by their medical providers, they still pursued alternative treatments. They had all
conducted research on these options and were continuing to seek information. Not one of
the participants suggested that the treatment she selected was the only appropriate option.
Perhaps most impressive was how attuned the participants were to their bodies.
They were able to notice small changes in their physical well-being and could attribute
these to minor changes they had made, whether these were medicinal or food related.
Participant 2 noted that she was “desperate to be well.” This desperation led her to try
various diets until she was able to fine-tune what worked for her. Participant 1 and
Participant 2 stressed the importance of self-care in their treatment of PD. Participant 6
reported stress as a trigger for her PD symptoms. She noted that she had learned over
time to pay attention to her body emotionally and physically.
One theme that surprised me was that none of the participants had permanently
ruled out pharmaceutical intervention. Each participant expressed concern about the PD
progressing and about permanent joint damage. Participant 3 stated that she knew that at
some point she would have to resort to pharmaceutical treatments. However, she noted
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that she felt she had “some control” over her diagnosis and “you are what you eat.” The
participants had an understanding that the treatment of PD was to be multifaceted. Each
participant took a scaffolding approach in which she had a system of where she wanted to
start with treatment. This scaffolding approach involved the participant looking toward
the future and how she would add to her treatment. Participant 4 stated that she was
satisfied with her current treatment option. No participant stated that she would eschew
natural treatment options to pursue pharmaceutical interventions.
The motivation for these participants was to avoid possible side effects that could
be life-threatening. Numerous participants stated they were concerned about the side
effects of prescription treatments. Participants noted their distrust of the medical
providers in how quickly the medical providers sought to prescribe medications with such
serious side effects. Participant 7 stated she was specifically scared of the increased risk
of cancer that accompanies pharmaceutical interventions for PD. In addition to the fear
of cancer, Participant 1 reported she was also concerned about the side effects of
medications that include hair loss or even death. Participant 2 described taking
pharmaceutical treatments as “poisoning my body.” She went on to describe herself as
“not a very cooperative patient.”
RQ2. How do they feel about the treatment decision they made, and what
benefits have they noticed?
None of the participants took lightly the severity and unpredictability of the
disease. Rather, they looked at the long-term effects of the disease and their treatment
options. Every participant conducted her own research to determine a treatment plan that
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worked for her. Participants 2, 4, and 7 reported seeing a naturopath. Participant 5 stated
her acupuncturist brought to her attention specific Chinese formulas. Participant 3, who
resides in England, reported she sees an osteopath and a physiopath. While each
participant reported being currently satisfied with her treatment choice, a few stressed
that they wanted to ensure that they exhausted all avenues prior to using pharmaceutical
interventions. Participant 3 noted that she felt “good at the moment” about her treatment
option. Participant 1 boldly stated that while she was “okay” with her current treatment
regimen, “Pain changes my mind.” These two comments illustrate the unknown of PD
and the underlying fear of the unknown.
A noticeable aspect of their treatment options that was missing was support from
their medical providers. Participant 5 described her rheumatologist as “bored” when he
gave her the diagnosis of PD. She noted he was also callous in his description she would
have to deal with this disease for the remainder of her life. Participant 4 stated she felt
that her rheumatologist was not “vested” in her. However, she noted her dermatologist
was “amazing” and worked to advocate for her treatment choice. Those with PD may see
various medical personnel that includes a rheumatologist, dermatologist, and primary
care provider. Participant 3 stated she did not feel there was good coordination between
her medical providers which further led her to seek out her own treatment route. Most of
the participants reported their medical providers strongly suggested biologics or
methotrexate. Few participants informed their medical providers of their treatment plan.
Participant 4 was told by her medical provider she would be back after she explored
dietary options. Participant 2 stated she wished that medical providers know more about
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the impact of nutrition. She noted her medical provider eventually agreed to her natural
approach. Participants 6 and 7 stated they continue to see their medical providers as mere
check-ins due to insurance and a desire to stay on the patient load. There was concern on
the part of some participants that should their PD progress, they would not be able to be
seen by a medical provider. Participant 1 stated she felt dismissed by her medical
provider. She noted she had made an effort to improve her attitude and listen to her
body. The general consensus among the participants was how they approached their PD
treatment each day. All participants reported this as an ongoing process in which they
stick with what works and adjust when needed. Each participant understood the
importance of the short-term and long-term effects of treatment options. Participants 1
and 2 stated they felt that their natural treatment choices were less harmful and
potentially better than what medical providers prescribed. Participant 3 noted she
understands she needs to put in the effort to treat her PD. The participants were all
willing to make sacrifices in giving up certain foods. They also all worked to incorporate
appropriate supplements, vitamins, and exercise. Based on their statements, once they
resolved to treat their PD non-pharmaceutically, they pursued this avenue with zeal and
determination.
Summary
This chapter laid out the themes and findings from the research. Each interview
portrayed the empowerment of these participants and their confidence that they knew
how to treat PD. While few of the participants felt supported by their medical
professionals, this perceived lack of support did not deter them from pursuing what they
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felt was right for them. Their willingness to conduct research on their own and try
various treatment options demonstrated their drive and resolve to treat themselves
naturally.
The following chapter provides interpretations of the findings of the research. In
addition, Chapter 5 lays out the limitations of this study. Finally, implications for social
change, directions for future research, and recommendations for practice are provided.
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Chapter 5: Discussion, Conclusions, and Recommendations
The purpose of this study was to examine the lived experience of women with PD
who have chosen to use alternative treatments as opposed to pharmaceutical
interventions. In this study, I sought to fill the gap in the literature as to how women
make decisions about their treatment of PD. Another purpose of the study was to provide
increased understanding of this population, which could be beneficial to those diagnosed
with PD and the physical and mental health practitioners who work with them. I used a
qualitative approach to allow for a deeper understanding of the participants and their
thought processes through determining their treatment plans. The specific methodology
was phenomenology. With the phenomenological approach I sought to describe the lived
experiences of these women in terms of how they went through the process of deciding
on a treatment plan. Most of the research that has been conducted in this area has not
examined the lived experience of women with PD (Magin et al., 2009). Participants were
interviewed until I reached data saturation.
This study showed that women are not generally supported by medical
professionals when they choose nonpharmaceutical approaches. These participants
trusted themselves enough to know that even without this support, their knowledge of
their health and values was enough for them to pursue alternative treatments. They
researched on their own and developed treatment plans that were unique to them.
Perhaps the most profound finding was that the treatment is an ongoing process. All of
the participants noted that they were continually researching treatment options and
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paying attention to their bodies. They adjusted their treatment as needed. In addition, it
was not that pharmaceutical treatment was to not be utilized; rather, patients sought to
use pharmaceutical interventions as a last resort due to the risks associated with
pharmaceutical interventions.
This final chapter integrates the research findings with the current literature. I
also discuss limitations of the study and recommendations for further research. Chapter 5
concludes with a description of the positive social change that may result from this study.
Interpretation of Findings
I chose women with PD for this study because they were shown to have a lower
quality of life than men diagnosed with PD (Hammadi, 2016; Magin et al., 2009). Selfin-relationship theory was used for this study with the understanding that women look at
themselves relationally. From this perspective, women deciding on a treatment plan are
likely to take into account how their relationships may be impacted by their treatment
plan. However, few women in the study mentioned their relationships. One participant
who disclosed that she had young children clearly stated that her being a mother of young
children was an important factor when she decided on a treatment plan. While others
talked about themselves relationally in regard to work and family, few clearly stated that
was an integral factor in their choices. Rather, the applicability of self-efficacy theory
was evident, as each participant felt competent enough to pursue the treatment option of
her choice. Some of these options included strict diets. Each participant was committed
to her treatment plan, knowing that it allowed her to live the life she desired, regardless of
her diagnosis.
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Research has shown that pharmacological options have lower efficacy with
women than they do with men (Eder et al., 2012). Astin’s (1998) study indicated that
people may be more likely to choose alternative therapies if they have more education,
poorer health status, and experience chronic pain. In this study, level of education was
not asked; however, each participant sought out resources to educate herself on PD, the
treatment options available, and potential side effects of pharmaceutical interventions.
Some of the participants had previous health crises and were already informed about
treatments. This helped give them insight and confidence in determining what they
wanted. Many participants researched attacking the root cause of the symptoms as
opposed to solely treating the symptoms. While the cause of PD is not yet known,
participants researched on their own and felt that gut health, allergies, and stress were
contributing factors to be targeted. In addition, Aujoulat et al. (2006) specifically
mentioned that effectiveness of self-empowerment can be dependent on the health care
provider providing a patient-centered approach. The research in this current study
indicated that the health care provider’s approach was not relevant to how the participant
chose to treat her PD. Rather, the participants had felt secure in their decisions to forgo
pharmaceutical interventions. The medical professionals’ approaches were not influential
in that respect. However, the medical professionals’ approaches impacted the
participants’ views and trust in their treatment providers. Participants reported that they
were more apt to switch medical providers than pursue pharmaceutical interventions.
Many participants reported that their primary purpose in continuing with their medical
care providers was to stay in the system should they need further care in the future. They
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reported that they did not seek out their physicians’ approval and instead simply informed
them of their treatment option.
Limitations of Study
Limitations of the study included transferability, interview quality, and biases.
Due to the qualitative approach, few participants were used in this study. It is impossible
to say that their experiences would reflect all women who pursue alternative treatment for
PD. In addition, some of the participants had experienced other health concerns that not
all of those with PD encounter. The interview questions may also have lacked sufficient
scope. I was limited by the interview guide. While this helped to keep interviews
consistent and structured, it left information missing. Perhaps the most important factor
was the lack of questions directly pertaining to relational impact and educational level.
The interview method did not appear to be a limitation. While Facetime did not
consistently work, I felt that audio calls allowed for rapport to be established and did not
interfere with the quality of the interviews. The most prominent limitation may have
been my bias. While I was aware of biases given my journey with PD, it was difficult for
me to discuss my treatment option with participants. I experienced a feeling of
inadequacy. However, I could also relate to many of the participants’ stories and
understood the importance of conveying the participants’ experiences from their unique
perspective. I frequently checked this bias, and the participant’s review of the summaries
was a vital component in eliminating this bias. Only one participant did not reply to the
summary reviews.
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Recommendations and Implications
Recommendations based on this study are focused on the advancement of
supporting women with PD who pursue alternative treatments. Papoutsaki and Costanzo
(2013) described the negative impact that PD can have on a person’s quality of life.
There is an unpredictability with PD that is stressful and alarming. The participants
eloquently stated their fear of the unknown with PD. Professionals in the mental health
community need to be aware of this population and their susceptibility to anxiety and
depression. The first recommendation would be to study how to support these women
within the mental health community. Mental health professionals should consider how
best to reach this population and how to effectively support its members. Further
research specifically targeting the mental well-being of this population would be
valuable. This future research should focus on whether this population seeks out mental
health services. Future research could also examine if this population has found support
within the mental health community. This research will allow for a better understanding
of this population’s perspective and what its members need from mental health
professionals. The members of the mental health community need to know where they
can be of most assistance to those diagnosed with PD who treat without pharmaceutical
interventions. Supporting their mental well-being could help improve their quality of
life, as well as their self-efficacy. Self-in-relation theory suggests that women’s
relational perspective ought to be a central focus. Mental health professionals have the
ability to lend a safe and supportive environment for these women to sort through the
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impact that PD has had on them as a whole. This mental health treatment should
encompass relational and personal impacts.
Another recommendation is to take a proactive approach to examining PD. While
the cause of PD is unclear and multifaceted, it is known that emotional well-being can
impact the development of PD (Leavitt, 2015). Further research in the etiology of PD is
vital. The mental health community could play a significant role in conducting such
research. The mental health community is needed to not only provide support for those
with PD, but also to study how PD develops and what conditions may precede its
development. One percent to 3% of the world population is affected by PD (Eder et al.,
2012). There is no definitive cause or cure for this disease. As previously mentioned,
mental health issues can precede and accompany PD. A social change implication of this
research is that it could provide help for mental health professionals to become more
aware of this vulnerable and frequently overlooked population. If those who treat their
PD naturally do not feel support in the medical community, perhaps the mental health
community can help to bridge this gap. The findings of this study indicated that these
participants do not feel supported by their medical care providers. In addition, they
reported feeling dismissed by medical providers who they turned to for help. They had
taken it on themselves to determine their treatment plans and to monitor this process.
These results may lead mental health professionals to look more closely at this
population, understand its members’ vulnerability, and determine approaches to actively
seek them out. This population can be reached on social media platforms or in the
community. Mental health professionals can lead workshops to bring attention to the
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comorbidity between PD and mental disorders. These workshops can help bring
attention to the comorbidity of mental disorders and PD. This study brought to attention
the lack of support that this population feels from the medical community. Raising this
awareness will provide necessary knowledge of what to look out for in their mental wellbeing and how to seek appropriate interventions. It will also show this population that
the mental health community is supportive of their treatment choice and ready to assist as
needed, according to the needs of the person.
Conclusion
I conducted this study with the intent of bringing a voice to those who have not
been heard. When society seeks to support the vulnerable, the population of women
diagnosed with PD who treat naturally cannot be overlooked. At this point in time,
people are more willing to seek out natural alternatives as a way to regain control of and
maximize their health (Astin, 1998). This study has come at an appropriate time to bring
attention to this plight. Perhaps most impactful will be making mental health
professionals aware of this population and spurring them to seek out ways to engage them
and promote their self-efficacy and mental well-being.
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Appendix A: Confidentiality Agreement
CONFIDENTIALITY AGREEMENT
Name of Signer:
During the course of my activity in collecting data for this research: “Examining the lived
experience of women with psoriatic disease who choose to treat their disease without
pharmaceutical intervention” I will have access to information, which is confidential and
should not be disclosed. I acknowledge that the information must remain confidential,
and that improper disclosure of confidential information can be damaging to the
participant.
By signing this Confidentiality Agreement I acknowledge and agree that:
1. I will not disclose or discuss any confidential information with others, including
friends or family.
2. I will not in any way divulge, copy, release, sell, loan, alter or destroy any
confidential information except as properly authorized.
3. I will not discuss confidential information where others can overhear the
conversation. I understand that it is not acceptable to discuss confidential information
even if the participant’s name is not used.
4. I will not make any unauthorized transmissions, inquiries, modification or purging of
confidential information.
5. I agree that my obligations under this agreement will continue after termination of
the job that I will perform.
6. I understand that violation of this agreement will have legal implications.
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7. I will only access or use systems or devices I’m officially authorized to access and I
will not demonstrate the operation or function of systems or devices to unauthorized
individuals.
Signing this document, I acknowledge that I have read the agreement and I agree to
comply with all the terms and conditions stated above.

Signature:

Date:
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Appendix B: Interview Questions
Lived Experience of the Decision-making Process in Women with Psoriatic Disease
Regarding Natural Alternative Treatment Options Questions
A. Questions Related to the Lived Experience of the Decision-making Process in Women
with Psoriatic Disease Regarding Natural Alternative Treatment Options
1.

What treatment options were presented to you after you were diagnosed?

2.

How did you become aware that treatment options besides pharmaceutical
interventions were available?

3.

What is your current treatment plan?

4.

How do you stay current on what treatment options are available to for PD?

5.

What was your thought process when deciding that pharmaceutical treatment was
not what you wanted?

6.

What were the contributing factors in the decision?

7.

How do you feel about the choice you made?

8.

Did you discuss your decision with your doctor?

9.

How did your doctor respond?

10.

Do you regularly go to a medical doctor for disease management?

11.

Do you see any other medical professionals, such as a naturopathic physician?

